TW200808173A - Agent for prevention of leakage of body fluid from dead body - Google Patents

Agent for prevention of leakage of body fluid from dead body Download PDF

Info

Publication number
TW200808173A
TW200808173A TW096123798A TW96123798A TW200808173A TW 200808173 A TW200808173 A TW 200808173A TW 096123798 A TW096123798 A TW 096123798A TW 96123798 A TW96123798 A TW 96123798A TW 200808173 A TW200808173 A TW 200808173A
Authority
TW
Taiwan
Prior art keywords
body fluid
leakage preventing
preventing agent
fluid leakage
water
Prior art date
Application number
TW096123798A
Other languages
Chinese (zh)
Inventor
Tatsuya Doi
Original Assignee
St Kikaku Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Kikaku Ltd filed Critical St Kikaku Ltd
Publication of TW200808173A publication Critical patent/TW200808173A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G17/00—Coffins; Funeral wrappings; Funeral urns
    • A61G17/04—Fittings for coffins
    • A61G17/047—Devices for absorbing decomposition liquid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

An agent for preventing the leakage of a body fluid, comprising a viscous base solution comprising (A) at least one solvent selected from the group consisting of a hydrophilic ether and a hydrophilic ether, (B) at least one dispersion-stabilizer selected from the group consisting of a polyalkyleneoxide-type thermoplastic nonionic water-absorbable resin, a carboxyvinyl polymer (which is a polymer of acrylic acid), a carboxyvinyl polymer (which is a polymer of acrylic acid)/an alkali-neutralizing agent, lipophilic smectite, synthetic hectorite, natural hectorite and bentonite, and/or (C) a thickening agent such as an urethane resin, polyvinyl ether, ethyl cellulose and polyethylene oxide and (D) a highly water-absorbable resin powder dispersed in the viscous base solution. The agent can be injected and filled into a body cavity of a dead body with an injection tool. When the agent contacts with a body fluid in the body cavity, the agent absorbs the body fluid rapidly, and then swells and is solidified.

Description

200808173 九、發明說明 【發明所屬之技術領域】 本發明係關於藉由裝塡於遺體的口、鼻、耳、肛門、 女性的陰道等之體腔而封閉，用以防止體液自遺體漏出之 油性凝膠狀之體液漏出防止劑。 【先前技術】 一般而言，人類或動物於死亡後體腔各部份的肌肉弛 緩，胃液、肺液、腹水、排泄物等之體液多會漏出，成爲 惡臭、或因病原菌感染之原因。因此，例如於醫院，於確 認死亡後’於遺體的口、鼻、耳、肛門、女性的陰道等之 體腔，進行裝塡大量的紗布、脫脂棉等，防止體液漏出。 另外，對於事故或手術後之遺體開口部份亦採取相同處理 。然而，裝塡紗布、脫脂棉等於體腔之作業，大多係藉由 從業者或護士等之手進行，該作業的煩雜或不衛生，同時 因爲紗布、脫脂棉等之吸水能力低，而有於作業中或作業 後經常漏出體液之問題，或亦有從事作業中因該漏出物質 而死後感染之可能性，強烈要求該解決方法。 因此，已知取代紗布、脫脂棉等，裝塡高吸水性樹脂 粉末於口、鼻、耳、咽喉等，已知例如使用注射器，裝塡 高吸水性樹脂粉末於口、鼻、耳之方法（參考專利文獻1 )、將含安定化二氧化氯之吸水性樹脂粉末，直接使用粉 末於咽喉，以水溶性薄片包住使用耳孔、鼻孔之方法（參 考專利文獻2)等。然而，即使裝塡如此高吸水性樹脂粉 -4- 200808173 末，因爲流動性差，裝塡於狹窄的體腔，例如咽喉部位、 肛門等係困難的。另外，僅爲鼻孔或耳孔之入口部份時， 可以如注射器之注入器充塡如此的微粉末，但不能充塡至 深處。另外，爲充塡至深處，注射器必須一邊動一邊充塡 時’由先端出來的微粉末飛散，反而污染遺體周圍。 爲解決如此高吸水性樹脂粉末之充塡性或作業性差或 飛散等之問題，近年來提出使用凝膠而非粉體，已知例如 使用以適量的水溶解加入除臭劑之粉末聚合物，適當混合 而成凝膠狀物之方法（參考專利文獻3 )、或使用以二甲 基丙烯醯胺爲主要成份之兩性凝膠之方法（參考專利文獻 4 )、使用於以醇爲主要成份之凝膠中，分散許多高吸水 性聚合物粉體之方法（參考專利文獻5)。 關於充塡如此之凝膠狀體液漏出防止劑於例如鼻孔深 處之咽喉部位時之充塡方法，參考圖1下說明時，如專利 文獻5記載，收納凝膠狀體液漏出防止劑2於注入器1係 具備由後端處自在滑動地插入之活塞3以及該先端被覆保 護蓋5之注入口 4，以薄膜包裝（未圖示）包住之密封狀 態。插入咽喉部位B等體腔之插入管6係一端具有連接注 入器1之注入口 4之連接部份7，另一端具有插入鼻孔八 之開口部份8。 接著，說明使用如此準備之遺體處理裝置之方法。圖 1中，A係鼻孔、B係咽喉部位、C係舌、D係氣管、e係 食道。使用時，自薄膜包裝取出注入器1，卸下注入器1 之注入口 4之保護蓋5，嵌入插入管6之連接部份7於注 -5- 200808173 入口 4 ’連接插入管6。接著，將插入管6之開口部份8 自鼻孔A朝向咽喉部位B插入，當插入管6之制止部份9 碰到鼻尖B時，停止插入。接著，推壓注入器1之活塞3 ’使注入器1內之凝膠狀體液漏出防止劑2經由插入管6 ’注入咽喉部位B。壓出注入器1內之凝膠狀體液漏出防 止劑2，充塡後，自鼻孔A除去注入器1及插入管6。 如上述之凝膠狀體液漏出防止劑係具有流動性高，即 使鼻孔、耳孔等之狹窄體腔，仍容易充塡，即使以注入器 壓入並不飛散之優異。尤其，使分散許多高吸水性聚合物 粉體之凝膠時，吸水性能高，此聚合物吸收自體腔漏出的 體液，將可防止漏出於外部。然而，因爲傳統之凝膠狀體 液漏出防止劑係添加凝膠化劑於水或醇而使成凝膠狀者， 所以以注入器具注入、裝塡後之吸液速度慢，因此，有因 死後體腔各部份之肌肉弛緩而體液容易漏出之問題。另外 ，就剛注入、裝塡於體腔後之吸液能力上亦稱不上足夠， 並且就經過長期間安定，保持凝膠狀之安定性上亦有改善 的空間。 〔專利文獻1〕特開平1 0 — 29800 1號公報（專利申請 範圍） 〔專利文獻2〕特開平7 — 265367號公報（專利申請 範圍） 〔專利文獻3〕特開平8 - 1 3 3 90 1號公報（專利申請 範圍） 〔專利文獻4〕特開2001— 288002號公報（專利申請 200808173 範圍） 〔專利文獻5〕特許第3 5 86207號公報（專利申請範 圍） 【發明內容】 & 發明之揭示 發明所欲解決之課題 Φ 因此，本發明之基本目的係提供以注入器具注入、裝 塡於遺體體腔，於體腔內與體液接觸時，迅速地吸收體液 ，膨潤而凝固，可有效地防止體液漏出之遺體的體液漏出 防止劑。 另外，本發明之目的係提供可容易調製具有可作業性 佳地注入、裝塡於遺體體腔之適當的流動性及黏彈性之凝 膠狀，以及可保持該狀態安定之遺體的體液漏出防止劑。 ® 課題之解決手段 爲達成上述目的，由本發明提供於含有至少1種選自 ^ 親水性的醚及酯所成群之溶劑（A)、及至少1種選自聚 環氧化物系之熱可塑性非離子型吸水性樹脂（具有聚環氧 化物基之非離子性熱可塑性·吸水性樹脂）、丙烯酸聚合 物之羧乙烯基聚合物、丙烯酸聚合物之羧乙烯基聚合物/ 鹼中和劑（羧乙烯基聚合物之鹼金屬鹽）、親油性蒙脫石 、合成鋰蒙脫石、天然鋰蒙脫石、及膨潤土所成群之分散 安定劑（B )及/或增黏劑（C )之黏稠液基劑中，分散高 200808173 吸水性樹脂粉末（D )爲特徵之遺體的體液漏出防止劑。 於適合的形態，上述溶劑（A )係至少1種選自聚環 氧乙烷二甲基醚及聚環氧乙烷脂肪酸二酯所成群。 另外，其他適合的形態，上述分散安定劑（B )係聚 環氧化物系之熱可塑性非離子型吸水性樹脂。 進而，其他適合的形態，上述增黏劑（C )係至少1 種選自聚胺基甲酸乙酯樹脂、聚乙烯醚、乙基纖維素及聚 環氧乙烷所成群。 尤其適合的形態係使用作爲上述分散安定劑（B )之 聚環氧化物系之熱可塑性非離子型吸水性樹脂，以及至少 1種之聚胺基甲酸乙酯樹脂、聚乙烯甲基醚、含45至50% 之環氧乙基之乙基纖維素及聚環氧乙烷之增黏劑（C)之 混合系。 另外，本發明之體液漏出防止劑，可更含有至少1種 選自與水混合時發熱之液狀非離子性界面活性劑（E )及 可溶於水之醇系有機溶劑（F )所成群，亦可再含有至少 1種選自殺菌劑、防黴·防腐劑、除臭劑及香料所成群。 發明之功效 因爲本發明之遺體的體液漏出防止劑係於含有至少1 種選自親水性的醚及酯所成群之溶劑（A )、及至少1種 選自聚環氧化物系之熱可塑性非離子型吸水性樹脂、丙嫌 酸聚合物之羧乙烯基聚合物、丙烯酸聚合物之羧乙烯基聚 合物/鹼中和劑（羧乙烯基聚合物之鹼金屬鹽）、親油性 -8- 200808173 蒙脫石、合成鋰蒙脫石、天然鋰蒙脫石、及膨潤土所成群 之分散安定劑（B)及/或聚胺基甲酸乙酯樹脂、聚乙烯醚 、乙基纖維素、聚環氧乙烷等之增黏劑（C)之黏稠液基 劑中’分散高吸水性樹脂粉末（D )之油性凝膠狀物，所 以以注入器具注入、裝塡於遺體體腔，於體腔內與體液接 觸時’迅速地吸收體液，膨潤而凝固成無流動性之固態凝 膠狀（固體凝膠），由此可有效地進行防止體液漏出。 # 另外，依據本發明之體液漏出防止劑之適合形態，因 爲上述溶劑（A)係至少1種選自聚環氧乙烷二甲基醚及 聚環氧乙烷脂肪酸二酯所成群，所以可容易調製具有可作 業性佳地注入、裝塡於遺體體腔之適當流動性及黏彈性之 凝膠狀，以及因爲作爲上述分散安定劑（B )之聚環氧化 物系之熱可塑性非離子型吸水性樹脂，以及作爲上述增黏 劑（C)之至少1種選自聚胺基甲酸乙酯樹脂、聚乙烯醚 、乙基纖維素及聚環氧乙烷所成群之混合系，所以可更確 ® 實地維持與體液接觸時之上述高吸水性樹脂粉末（D )之 均勻分散狀態。因此，於含有組合如上述之溶劑（A )及 • 分散安定劑（B )及/或增黏劑（C )之黏稠液基劑中，分 . 散高吸水性樹脂粉末（D )之體液漏出防止劑係可安定地 保持具有可作業性佳地注入、裝塡於遺體體腔之適當流動 性及黏彈性之凝膠狀狀態，並且注入、裝塡於遺體體腔時 ，整體迅速地吸收體液，膨潤而凝固成無流動性之固態凝 膠狀，可更有效地進行防止體液漏出。 另外，本發明之體液漏出防止劑，藉由更含有作爲助 -9 - 200808173 溶劑之至少1種選自與水混合時發熱之液狀非離子性界面 活性劑（E)及可溶於水之醇系有機溶劑（F )所成群，將 容易調整黏度，使流動性升高，即使於咽喉部位等之狹窄 體腔，將可更順利地注入、裝塡。尤其含有與水混合時發 熱，迅速地可溶於水之液狀非離子性界面活性劑（E )時 ，藉由與體液接觸時之上述非離子性界面活性劑（E )之 發熱作用，可提高上述高吸水性樹脂粉末（D )之吸液速 度。進而，藉由含有至少1種選自殺菌劑、防黴·防腐劑 、除臭劑及香料所成群，亦可合倂此等所需效果而發揮。 用以實施發明之最佳形態 本發明者爲解決上述傳統問題努力硏究的結果係發現 於含有至少1種選自親水性的醚及酯所成群之溶劑（A ) 、及溶解於其之上述特定之分散安定劑（B )及/或增黏劑 (C )之黏稠液基劑中，使分散高吸水性樹脂粉末（D )而 成之油性凝膠狀體液漏出防止劑，於注入、裝塡於遺體體 腔時，迅速地吸收體液，膨潤而凝固成無流動性之固態凝 膠狀，而完成本發明者。爲何可得到如此效果，雖然尙未 明確，但認爲係因爲至少1種選自親水性的醚及酯所成群 之溶劑（A )亦如作爲洗淨劑用溶劑使用，爲親水性，並 且亦具有優異的油脂類溶解性，所以與不僅含水份亦含有 油脂份之遺體體液之親和性優異。另外，因爲爲親油性， 所以可分散較多量之高吸水性樹脂粉末（D )，並且溶解 上述特定之分散安定劑（B )及/或增黏劑（C )於如此溶 -10- 200808173 劑（A )中之黏稠液基劑中，使分散高吸水性樹脂粉末（ D )而成之本發明之油性凝膠狀體液漏出防止劑之安定性 亦優異。 以下係說明有關本發明之體液漏出防止劑之各成份。 首先，作爲至少1種選自親水性的醚及酯所成群之溶 劑（A)，醚及酯中之只要於室溫（20±5°C )下顯示親水 性之液狀化合物即可使用，尤其可適合使用至少1種選自 聚環氧乙烷二甲基醚及聚環氧乙烷脂肪酸二酯所成群。聚 環氧乙烷脂肪酸二酯係以一般式RCOO ( CH2CH20 ) nCOR 表示，作爲烷基R係以碳原子數爲17個以下爲宜，可舉 例如聚乙二醇二月桂酸酯、聚乙二醇二油酸酯等。此等中 係以聚環氧乙烷二甲基醚尤佳。另外，此等溶劑之聚合度 亦只要於室溫（20±5°C )下爲液狀之聚合度即可，並非特 別侷限者。 但因爲此等溶劑（A )於室溫下爲無黏性之液狀，所 以必須溶解上述分散安定劑（B )及/或增黏劑（C )以提 高組成物的黏性。不添加分散安定劑（B )及/或增黏劑（ C )時，由注入器壓入所得之體液漏出防止劑於體腔內時 ，溶劑先自注入器先端出來，固形物容易阻塞於注入器先 端部份，變得難以注入。 上述溶劑（A)之含量係以體液漏出防止劑整體量之 約30〜85質量％爲宜，以約40〜80質量％尤佳，以約50 〜70質量％更好。配合大量而溶劑（A)之含量超過85質 量％時，雖然無高吸水性樹脂粉末分散性之問題，但因爲 -11 - 200808173 難以成爲凝膠狀，近於溶液之狀態，所以並不適宜。另一 方面，溶劑（A )之含量過低時，因爲將難以形成良好的 凝膠狀態，所以不適宜。 本發明使用之分散安定劑（B)係用以保持高吸水性 樹脂粉末之均勻分散狀態者，可使用至少1種選自可吸收 各種電解質水溶液，幾乎不受電解質濃度影響之聚環氧化 物系之熱可塑性非離子型吸水性樹脂、丙烯酸聚合物之羧 乙烯基聚合物、丙烯酸聚合物之羧乙烯基聚合物/鹼中和 劑（羧乙烯基聚合物之鹼金屬鹽）、親油性蒙脫石、合成 鋰蒙脫石、天然鋰蒙脫石、及膨潤土所成群。此等之分散 安定劑（B )中，以聚環氧化物系之熱可塑性非離子型吸 水性樹脂爲宜，此樹脂係可吸收各種電解質水溶液，幾乎 不受電解質濃度影響，可吸收酸或鹼性水溶液。但是僅使 用此樹脂作爲分散安定劑時，因爲所得之凝膠狀物有略硬 之傾向’注入時之滑順性上略有困難，所以以作爲分散安 定劑（B )之聚環氧化物系之熱可塑性非離子型吸水性樹 脂’以及至少1種選自聚胺基甲酸乙酯樹脂、聚乙烯甲基 醚、含45至5 0%之乙氧基之乙基纖維素及聚環氧乙烷之 增黏劑（C )之混合系爲宜。 分散安定劑（B )之含量係以體液漏出防止劑整體量 之約0.5〜40質量％爲宜，以約1〜30質量％尤佳。分散安 定劑（B )之含量若過低時，將難以保持高吸水性樹脂粉 末之均句分散性，另一方面，即使配合多量而超過40質 量’未見其以上之效果，就經濟性上並不適宜。 •12- 200808173 上述增黏劑（c )係用以提高組成物黏性，形成安定 的油性凝膠狀物所添加者。作爲增黏劑（C )，並無特別 的限定，可適合使用至少1種選自聚胺基甲酸乙酯樹脂、 聚乙烯醚、乙基纖維素、聚環氧乙烷、羧甲基纖維素鈉、 羧甲基纖維素、甲基纖維素、聚乙烯醇、聚乙烯吡咯烷酮 、sola gum、及褐藻酸鈉所成群之增黏劑。此等中係以聚 胺基甲酸乙酯樹脂、聚乙烯醚、乙基纖維素及聚環氧乙烷 爲宜。增黏劑之含量係以體液漏出防止劑整體量之約0.1 〜10質量％爲宜，以約0.2〜7質量％尤佳。 作爲本發明使用之高吸水性樹脂粉末（D )，可使用 傳統已知之各種局吸水性樹脂之粉末，但並非侷限於特定 物，可適合使用至少1種選自此等中之聚乙烯丙烯酸酯、 聚丙烯酸鹽、褐藻酸鹽、丙烯酸接枝共聚物交聯物、乙烯 醇與聚丙烯酸之共聚物、聚乙二醇系聚合物、聚丙烯醯胺 系樹脂、聚丙烯酸馬來酸之共聚物、聚環氧乙烷系聚合物 、及聚褐藻酸鹽系聚合物所成群。 上述高吸水性樹脂粉末（D )係以平均粒度約爲1 8〜 160網目（依戴勒（Tyier )表示）之粉體爲宜，以約3〇 網目〜140網目尤佳。 另外，高吸水性樹脂粉末（D )之含量係必須遺體內 之體液不自體腔漏出，立即吸收而膨脹，製成無流動性之 凝膠之必須量。高吸水性樹脂粉末之含量係以體液漏出防 止劑整體量之約5〜50質量％爲宜，以約15〜35質量。/。尤 佳。 -13- 200808173 本發明之體液漏出防止劑係加入上述各成份，因應需 要，亦可含有與水混合時發熱之於室溫爲液狀非離子性界 面活性劑（E )及/或可溶於水之醇系有機溶劑（F )作爲 助溶劑。 作爲本發明使用之與水混合時發熱之於室溫爲液狀非 離子性界面活性劑（E )，可舉例如椰子油脂肪酸單乙醇 醯胺、椰子油脂肪酸二乙醇醯胺1 : 1型、椰子油脂肪酸 二乙醇醯胺1: 2型、聚環氧乙烷椰子油脂肪酸單乙醇醯 胺、月桂酸二乙醇醯胺、聚環氧乙烷月桂基醚、聚環氧乙 烷鯨蠟醚、聚環氧乙烷高級醇醚、聚乙二醇（聚合度之平 均分子量爲600以下）、聚環氧乙烷聚環氧丙烷乙二醇（ 加成環氧乙烷於聚丙二醇之Pluronic型非離子界面活性劑 )、聚環氧乙烷烷基（烷基之碳原子數爲12〜14個）醚 (環氧乙烷之加成莫耳數：7〜12莫耳）等之聚環氧乙烷 烷基醚系、山梨糖醇酐脂肪酸酯系、聚環氧乙烷山梨糖醇 酐脂肪酸酯系等之界面活性劑，此等可以單獨或組合2種 以上使用。此等之非離子性界面活性劑（E )中，以液狀 之聚乙二醇（聚合度之平均分子量約爲200〜600)爲宜。 另外，嚴格上說來，聚乙二醇可說是非離子性界面活性劑 之先驅物，但於本說明書中分類成非離子性界面活性劑。 但是分類於後述之醇系有機溶劑（F )亦無妨。 此等液狀之非離子性界面活性劑（E )，尤其液狀之 聚乙二醇（聚合度之平均分子量約爲200〜600 )係可作爲 部份溶劑使用，於低溫（約30°C〜50°C )可容易溶解上述 -14- 200808173 之分散安定劑（B)，尤其聚環氧化物系之熱可塑 子型吸水性樹脂粉末，另外，與水混合時，如後述 例2所示，接觸水時發熱而水溫上升（上升1 〇°c〜 ’另外，因爲爲界面活性劑，所以與水之相容性佳 容易混合、溶解，如上所述提高高吸水性樹脂之吸 ，迅速地凝固成無流動性之固態凝膠狀，可防止體 〇 # 亦即，因爲一般高吸水性樹脂粉末（D )之吸 ，隨著溫度上升而有變高的傾向，所以藉由與體液 之上述非離子性界面活性劑（E〇之發熱作用，提 高吸水性樹脂粉末（D )之吸液速度，迅速地吸收 膨潤，可凝固成無流動性之固態凝膠狀。然而，因 速度愈高，所注入之凝膠狀物與體液接觸之表面部 地凝固成無流動性之固態凝膠狀，所以高吸水性樹 (D )之均勻分散性容易崩潰。另外，長時間放置 ® 凝膠狀之體液漏出防止劑時，變得容易分離。本發 液漏出防止劑中，於黏稠液基劑，再使溶解可吸收 _ 解質水溶液，幾乎不受電解質濃度影響之上述特定 安定劑（B)，保持高吸水性樹脂粉末（D )之均勻 ，但就上述觀點，上述非離子性界面活性劑（E ) 係以體液漏出防止劑整體量之約5 0質量％以下爲宜 3〜40質量％尤佳，以約5〜20質量％更好。 本發明之體液漏出防止劑係除了上述非離子性 性劑（E)之外，於不損及本發明功效之量的比率 性非離 之試驗 12°C ) ，與水 水速度 液漏出 水速度 接觸時 高上述 體液而 爲吸液 份迅速 脂粉末 所得之 明之體 各種電 之分散 分散性 之含量 ，以約 界面活 ，因應 -15- 200808173 需要，亦可含有陰離子性界面活性劑。 作爲陰離子性界面活性劑，可舉例如聚環氧乙焼院基 醚硫酸鹽系、聚環氧乙烷月桂基醚硫酸鈉、聚環氧乙焼月 桂基醚硫酸三乙醇胺、聚環氧乙烷烷基（烷基之碳原子數 爲1 1〜1 5個）醚硫酸鈉（環氧乙烷之加成莫耳數：3 )烷 基（烷基之碳原子數爲11、13、15個）三乙醇胺、烷基 硫酸鈉、烷基硫酸三乙醇胺、高級醇硫酸鈉等之烷基醚硫 酸系；聚環氧乙烷烷基磺基琥珀酸二鈉、聚環氧乙烷磺基 琥珀酸、聚環氧乙烷磺基琥珀酸月桂基二鈉、磺酸月桂基 二鈉、磺基琥珀酸聚環氧乙烷月桂基乙醇醯胺二鈉等之磺 基琥珀酸鹽系；十二烷基苯磺酸鈉等之烷基苯磺酸系等之 界面活性劑，此等係可以單獨或組合2種以上使用。 作爲醇系有機溶劑（F )，上述非離子性界面活性劑 或極性溶劑之可溶於水之溶劑都可使用，並無特別限定者 ，可適合使用至少1種選自乙二醇、丙二醇、二乙二醇、 三乙二醇、甘油、甲醇、乙醇、及異丙醇所成群之醇系有 機溶劑。此等醇系有機溶劑中，以甘油爲宜。甘油係容易 與水混合，雖僅有少量，但混合時水溫稍上升（約3 t ) 。因此，可幫助增加高吸水性樹脂之吸水速度，並且提升 所調製體液漏出防止劑之黏性，使流動性佳，低溫時，幫 助防止油性凝膠的凝固。 醇系有機溶劑之含量係以體液漏出防止劑整體量之約 20質量％以下爲宜，以約1〜10質量％尤佳。 本發明之體液漏出防止劑係因應需要，可再含有至少 -16- 200808173 1種選自殺菌劑、防黴·防腐劑、除臭劑、香料等其他添 加劑。 作爲殺菌劑，可舉例如異丙基甲基苯酚、氯胍（ chlorhexidine gluconate)、百里香酸、鄰苯基苯酌、焼基 二甲基苯甲基氯化錢、十六院基氯化B定（ Cety lpyridinium chloride ) 、氯化苯乙基錢（ B enzethonium chloride )、三氯沙（Triclosan) 、e 一 聚 賴胺酸、氯化溶菌酶（Lysozyme chloride)、檜木醇、葡 萄柚種籽萃取物、辣椒萃取物「Wasaouro」等，此等係可 以單獨或組合2種以上使用。 作爲防黴·防腐劑，可舉例如對羥基苯甲酸鈉、對經 基苯甲酸丁酯、對羥基苯甲酸丙酯、對羥基苯甲酸異丁酯 、苯甲酸鈉、丙酸鈉、腐絕（Thiabendazole )、異噻唑啉 酮（Isothiazolone)等，此等係可以單獨或組合2種以上 使用。 作爲除臭劑，可舉例如孟宗竹萃取物、綠茶萃取物、 長鏈甜菜鹼化合物、柿萃取液之總稱型丹寧爲主要成份之 消臭劑、混合數種植物萃取物之植物系特殊消臭劑等，此 等係可以單獨或組合2種以上使用。 另外，作爲香料，可舉例如花香調、根橘香調、水果 香調、木香調、新鮮（fresh note )調、混合香調、草香 調、薄荷調等之各種天然及人工香料。 如上述之殺菌劑、防黴·防腐劑、除臭劑及香料之含 量，就維持各成份所需效果，得到安全性及良好經濟性之 -17- 200808173 觀點上’於具有黏性.流動性之體液漏出防止劑整體之所 佔比率，殺菌劑及防黴防腐劑係以分別約爲0.001〜15質 量％爲宜，以約0.00 3〜8質量％尤佳。同樣地消臭劑係以 約爲〇·〇5〜20質量％爲宜，以約〇·1〜10質量％尤佳。另 外，香料係以約爲0.001〜10質量％爲宜，以約0.01〜5 質量％尤佳。其他，亦可添加含有色素，該配合量、色調 的選擇等並非特別的限定者，可任意設定。 # 含有如上述各成份之本發明之體液漏出防止劑之黏度 ，爲具有良好的流動性，以約6,000〜50,000cPs爲宜，以 約 10,00 0〜40,000。？3尤佳。 另外，在此所謂黏度係使用黏度計（美國Brookfield 社製，「數位黏度計」型式：DV - 1+)，以馬達轉軸（ spindle ) No.07，旋轉數：20rpm，使用體液漏出防止劑溫 度：20 °C之測定條件測定之値，但並非侷限於此者，以相 同條件測定之測定値即可。200808173 IX. Description of the Invention [Technical Fields of the Invention] The present invention relates to an oily condensation which is closed by a body cavity of a mouth, a nose, an ear, an anus, a woman's vagina, etc., which is attached to a body to prevent leakage of body fluids from the body. A colloidal body fluid leakage preventive agent. [Prior Art] In general, the muscles of various parts of the body cavity of humans or animals are relaxed, and body fluids such as gastric juice, lung fluid, ascites, and excretions are often leaked out, causing malodor or infection due to pathogenic bacteria. Therefore, for example, in a hospital, after confirming death, a body cavity such as a mouth, a nose, an ear, an anus, or a female vagina of a body is mounted, and a large amount of gauze, cotton wool, and the like are attached to prevent leakage of body fluid. In addition, the same treatment is applied to the opening of the remains after the accident or surgery. However, the operation of loading gauze and cotton wool equal to the body cavity is mostly carried out by a practitioner or a nurse, etc., which is troublesome or unsanitary, and because the gauze, the absorbent cotton, etc. have low water absorption capacity, and are in operation or The problem of frequent leakage of body fluids after work, or the possibility of infection after death due to leakage of material during work, is strongly demanded. For this reason, it is known to replace the gauze, the absorbent cotton, and the like with the superabsorbent resin powder in the mouth, the nose, the ear, the throat, and the like. For example, a method of attaching the super absorbent resin powder to the mouth, the nose, and the ear using a syringe is known (refer to Patent Document 1) A method in which a water-absorbent resin powder containing stabilized chlorine dioxide is used as a powder in a throat, and a method of using an ear hole or a nostril with a water-soluble sheet is used (refer to Patent Document 2). However, even if such a highly absorbent resin powder -4- 200808173 is installed, it is difficult to mount it in a narrow body cavity such as a throat portion or an anus because of poor fluidity. In addition, when it is only the entrance portion of the nostrils or ear holes, such a fine powder can be filled as an injector of a syringe, but it cannot be filled deep. In addition, in order to fill the depths, the syringe must be filled while moving. The fine powder from the apex scatters and contaminates the surrounding body. In order to solve the problems such as the chargeability or poor workability or scattering of such a highly water-absorptive resin powder, it has been proposed in recent years to use a gel instead of a powder, and it is known to use, for example, a powder polymer obtained by dissolving a deodorant in an appropriate amount of water. A method of appropriately mixing a gel (refer to Patent Document 3), or a method of using an amphoteric gel containing dimethyl acrylamide as a main component (refer to Patent Document 4), and using an alcohol as a main component In the gel, a method of dispersing a plurality of superabsorbent polymer powders (refer to Patent Document 5). When the method of filling the gelled body fluid leakage preventing agent in the throat portion of the nostril, for example, as described below with reference to Fig. 1, the gelled body fluid leakage preventing agent 2 is contained in the injection. The device 1 is provided with a piston 3 that is slidably inserted at the rear end and an injection port 4 that covers the protective cover 5 at the tip end, and is sealed in a film package (not shown). The insertion tube 6 inserted into the body cavity of the throat portion B has a connecting portion 7 connected to the injection port 4 of the injector 1 at one end, and an opening portion 8 inserted into the nostril 8 at the other end. Next, a method of using the thus prepared body treatment device will be described. In Fig. 1, A is a nostril, a B-throat portion, a C-system tongue, a D-system trachea, and an e-system esophagus. In use, the injector 1 is taken out of the film package, the protective cover 5 of the injection port 4 of the injector 1 is removed, and the connecting portion 7 of the insertion tube 6 is inserted into the insertion tube 6 at the inlet 4' of the -5-200808173. Next, the opening portion 8 of the insertion tube 6 is inserted from the nostril A toward the throat portion B, and when the stopper portion 9 of the insertion tube 6 hits the nose tip B, the insertion is stopped. Next, the piston 3' of the injector 1 is pushed so that the gelled body fluid leakage preventing agent 2 in the injector 1 is injected into the throat portion B via the insertion tube 6'. The gel-like body fluid that has been pushed out of the injector 1 leaks out of the inhibitor 2, and after filling, the injector 1 and the insertion tube 6 are removed from the nostrils A. The gelled body fluid leakage preventing agent as described above has high fluidity, and even if it is a narrow body cavity such as a nostril or an ear hole, it is easily filled, and it is excellent even if it is pressed by an injector. In particular, when a gel of a plurality of superabsorbent polymer powders is dispersed, water absorption performance is high, and the polymer absorbs body fluid leaking from the body cavity to prevent leakage to the outside. However, since the conventional gel-like body fluid leakage preventing agent is added to the gelling agent in water or alcohol to form a gel, the liquid absorption rate after the injection device is injected and mounted is slow, and therefore, there is a cause of death. The muscles of various parts of the body cavity are relaxed and the body fluid is easily leaked. In addition, the liquid absorbing ability just after being injected and mounted in the body cavity is not sufficient, and there is room for improvement in maintaining the gel-like stability after a long period of stability. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei 7-265367 (Patent Application No.) [Patent Document 3] Patent Publication No. 8 - 1 3 3 90 1 [Patent Document 4] [Patent Document 4] JP-A-2001-288002 (Patent Application No. 200808173) [Patent Document 5] Patent No. 3,056,207 (Patent Application) [Invention] SUMMARY OF THE INVENTION Accordingly, the basic object of the present invention is to provide an injection device that is injected into a body cavity of a body and rapidly absorbs body fluids when in contact with body fluids in a body cavity, swells and solidifies, and effectively prevents body fluids. The body fluid leakage prevention agent of the leaked body. Further, an object of the present invention is to provide a gel-like form which can be easily prepared and which is suitable for injection and is suitable for fluidity and viscoelasticity of a body cavity, and a body fluid leakage preventing agent capable of maintaining a stable body in this state. . ® Solution to the Problem In order to achieve the above object, the present invention provides a solvent (A) containing at least one selected from the group consisting of hydrophilic ethers and esters, and at least one thermoplastic selected from the group consisting of polyepoxides. Nonionic water-absorbent resin (nonionic thermoplastic/water-absorbent resin having a polyepoxide group), a carboxyvinyl polymer of an acrylic polymer, a carboxyvinyl polymer of an acrylic polymer / an alkali neutralizer ( a dispersing stabilizer (B) and/or a tackifier (C) in the group of alkali metal salts of carboxyvinyl polymers, lipophilic montmorillonite, synthetic hectorite, natural hectorite, and bentonite In the viscous liquid base, a body fluid leakage preventing agent having a high dispersion of 200,808,173 water-absorbent resin powder (D) is characterized. In a suitable form, the solvent (A) is at least one selected from the group consisting of polyoxyethylene dimethyl ether and polyethylene oxide fatty acid diester. Further, in another suitable embodiment, the dispersion stabilizer (B) is a polyepoxide-based thermoplastic nonionic water-absorbent resin. Further, in another suitable embodiment, the tackifier (C) is at least one selected from the group consisting of polyurethane resin, polyvinyl ether, ethyl cellulose, and polyethylene oxide. Particularly suitable form is a polyepoxide-based thermoplastic nonionic water-absorbent resin as the dispersion stabilizer (B), and at least one type of polyurethane resin, polyvinyl methyl ether, and A blend of 45 to 50% of ethylenylcellulose of ethylene oxide and a tackifier of (polyoxyethylene) (C). Further, the body fluid leakage preventing agent of the present invention may further comprise at least one selected from the group consisting of a liquid nonionic surfactant (E) which is heated when mixed with water, and an alcohol-soluble organic solvent (F) which is soluble in water. The group may further contain at least one selected from the group consisting of fungicides, mildew/preservatives, deodorants and perfumes. The effect of the invention is that the body fluid leakage preventing agent of the body of the present invention is a solvent (A) containing at least one selected from the group consisting of hydrophilic ethers and esters, and at least one thermoplastic selected from the group consisting of polyepoxides. Nonionic water-absorbent resin, carboxyvinyl polymer of acrylic acid polymer, carboxyvinyl polymer/alkali neutralizer of acrylic polymer (alkali metal salt of carboxyvinyl polymer), lipophilic-8- 200808173 Dispersing stabilizer (B) and/or polyurethane resin, polyvinyl ether, ethyl cellulose, poly in groups of montmorillonite, synthetic hectorite, natural hectorite, and bentonite In the viscous liquid base of the tackifier (C) such as ethylene oxide, the oily gel of the superabsorbent resin powder (D) is dispersed, so that it is injected into the body cavity of the body by the injection device, and is placed in the body cavity. When it comes into contact with body fluids, it quickly absorbs body fluids, swells and solidifies into a solid gel-like (solid gel) with no fluidity, thereby effectively preventing leakage of body fluids. Further, according to a preferred embodiment of the body fluid leakage preventing agent of the present invention, since the solvent (A) is at least one selected from the group consisting of polyethylene oxide dimethyl ether and polyethylene oxide fatty acid diester, It is easy to prepare a gel form which is excellent in workability, suitable fluidity and viscoelasticity which is attached to the body cavity of the body, and a thermoplastic non-ionic type which is a polyepoxide system as the dispersion stabilizer (B). The water-absorbent resin and the at least one kind of the above-mentioned tackifier (C) are selected from the group consisting of polyurethane resin, polyvinyl ether, ethyl cellulose, and polyethylene oxide. More precisely® maintains the uniform dispersion state of the above superabsorbent resin powder (D) in contact with body fluids. Therefore, in the viscous liquid base containing the solvent (A) and the dispersion stabilizer (B) and/or the tackifier (C) in combination with the above, the body fluid of the high water absorbent resin powder (D) is leaked out. The preventive agent can stably maintain the gel state of the proper fluidity and viscoelasticity which can be injected and mounted in the body cavity of the body, and can absorb the body fluid and swell quickly as a whole when being injected and mounted on the body cavity of the body. It is solidified into a solid gel form with no fluidity, which prevents the leakage of body fluid more effectively. Further, the body fluid leakage preventing agent of the present invention further contains at least one liquid nonionic surfactant (E) which is selected from the group consisting of a solvent of -9 - 200808173 and which is heated when mixed with water, and is soluble in water. When the alcohol-based organic solvent (F) is grouped, it is easy to adjust the viscosity and increase the fluidity, and it can be injected and mounted more smoothly even in a narrow body cavity such as a throat. In particular, when the liquid nonionic surfactant (E) which generates heat when mixed with water and is rapidly soluble in water, the heat of the nonionic surfactant (E) upon contact with the body fluid can be used. The liquid absorption speed of the above highly water-absorptive resin powder (D) is increased. Further, it can be exhibited by containing at least one selected from the group consisting of a bactericide, a mold, a preservative, a deodorant, and a fragrance. BEST MODE FOR CARRYING OUT THE INVENTION The inventors of the present invention have found that a solvent (A) containing at least one selected from the group consisting of hydrophilic ethers and esters is dissolved in a solution to solve the above-mentioned conventional problems. In the viscous liquid base of the specific dispersion stabilizer (B) and/or the tackifier (C), the oily gel-like body fluid leakage preventing agent which disperses the superabsorbent resin powder (D) is injected, When the body cavity is attached to the body cavity, the body fluid is rapidly absorbed, swollen and solidified into a solid gel form having no fluidity, and the inventors of the present invention have been completed. Why is it possible to obtain such an effect, although it is not clear, it is considered that the solvent (A) which is a group of at least one selected from the group consisting of hydrophilic ethers and esters is also used as a solvent for a detergent, and is hydrophilic, and Since it also has excellent oil-soluble solubility, it is excellent in affinity with body fluids which contain not only a moisture content but also a fat body part. In addition, since it is lipophilic, a large amount of the super absorbent resin powder (D) can be dispersed, and the above-mentioned specific dispersion stabilizer (B) and/or tackifier (C) can be dissolved in such a solvent. In the viscous liquid base of (A), the oily gel-like body fluid leakage preventing agent of the present invention obtained by dispersing the superabsorbent resin powder (D) is also excellent in stability. The components of the body fluid leakage preventing agent of the present invention are explained below. First, as a solvent (A) selected from at least one group selected from the group consisting of hydrophilic ethers and esters, a liquid compound which exhibits hydrophilicity at room temperature (20±5° C.) can be used as the ether and ester. In particular, it is suitable to use at least one selected from the group consisting of polyethylene oxide dimethyl ether and polyethylene oxide fatty acid diester. The polyethylene oxide fatty acid diester is represented by the general formula RCOO (CH2CH20) nCOR, and the alkyl group R preferably has 17 or less carbon atoms, and examples thereof include polyethylene glycol dilaurate and polyethylene. Alcohol dioleate and the like. Among these, polyethylene oxide dimethyl ether is particularly preferred. Further, the degree of polymerization of these solvents is also a liquid polymerization degree at room temperature (20 ± 5 ° C), and is not particularly limited. However, since these solvents (A) are in the form of a non-viscous liquid at room temperature, it is necessary to dissolve the above dispersion stabilizer (B) and/or the tackifier (C) to improve the viscosity of the composition. When the dispersion stabilizer (B) and/or the tackifier (C) are not added, when the body fluid leakage preventing agent is pressed into the body cavity by the injector, the solvent first comes out from the injector tip, and the solid matter is easily blocked in the injector. The tip part becomes difficult to inject. The content of the solvent (A) is preferably from about 30 to 85% by mass based on the total amount of the body fluid leakage preventing agent, more preferably from about 40 to 80% by mass, still more preferably from about 50 to 70% by mass. When the content of the solvent (A) is more than 85% by mass, the problem of dispersibility of the superabsorbent resin powder is not obtained, but it is not suitable because it is difficult to be in a gel state and is close to the state of the solution. On the other hand, when the content of the solvent (A) is too low, it is difficult to form a good gel state, which is not preferable. The dispersion stabilizer (B) used in the present invention is used to maintain a uniform dispersion state of the super absorbent resin powder, and at least one polyepoxide system selected from the group consisting of an aqueous solution capable of absorbing various electrolytes and hardly affected by the electrolyte concentration can be used. Thermoplastic nonionic water-absorbent resin, carboxyvinyl polymer of acrylic polymer, carboxyvinyl polymer/alkali neutralizer of acrylic polymer (alkali metal salt of carboxyvinyl polymer), lipophilic montmorillonite Stone, synthetic hectorite, natural hectorite, and bentonite are grouped. Among these dispersion stabilizers (B), it is preferred to use a polyepoxide-based thermoplastic nonionic water-absorbent resin which can absorb various aqueous electrolyte solutions and is hardly affected by the electrolyte concentration, and can absorb an acid or a base. Aqueous solution. However, when only the resin is used as the dispersion stabilizer, the resulting gel-like material tends to be slightly hard, and it is slightly difficult to perform smoothness upon injection, so that it is a polyepoxide system as a dispersion stabilizer (B). Thermoplastic nonionic water-absorbent resin' and at least one selected from the group consisting of polyurethane resin, polyvinyl methyl ether, ethyl cellulose having 45 to 50% ethoxy group, and polyethylene oxide A mixture of the agglomerates of the alkane (C) is preferred. The content of the dispersion stabilizer (B) is preferably from about 0.5 to 40% by mass based on the total amount of the body fluid leakage preventing agent, and particularly preferably from about 1 to 30% by mass. If the content of the dispersion stabilizer (B) is too low, it will be difficult to maintain the uniformity of the superabsorbent resin powder. On the other hand, even if it is blended in a large amount and exceeds 40 masses, the effect is not economically. Not suitable. •12- 200808173 The above tackifier (c) is used to increase the viscosity of the composition and form a stable oily gel. The tackifier (C) is not particularly limited, and at least one selected from the group consisting of polyurethane resin, polyvinyl ether, ethyl cellulose, polyethylene oxide, and carboxymethyl cellulose can be suitably used. A tackifier of sodium, carboxymethylcellulose, methylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, sola gum, and sodium alginate. Among these, polyurethane resin, polyvinyl ether, ethyl cellulose and polyethylene oxide are preferred. The content of the tackifier is preferably from about 0.1 to 10% by mass based on the total amount of the body fluid leakage preventing agent, and particularly preferably from about 0.2 to 7% by mass. As the superabsorbent resin powder (D) used in the present invention, a powder of various conventionally known water-absorbent resins can be used, but it is not limited to a specific one, and at least one polyethylene acrylate selected from the above may be suitably used. , polyacrylate, alginate, acrylic graft copolymer crosslinker, copolymer of vinyl alcohol and polyacrylic acid, polyethylene glycol polymer, polypropylene amide resin, polyacrylic acid maleic acid copolymer The polyethylene oxide polymer and the polyalginate polymer are grouped together. The above superabsorbent resin powder (D) is preferably a powder having an average particle size of about 18 to 160 mesh (indicated by Tyer), and preferably about 3 mesh to 140 mesh. Further, the content of the superabsorbent resin powder (D) is such that the body fluid in the body does not leak from the body cavity, and is immediately absorbed and expanded to form a necessary amount of the gel having no fluidity. The content of the superabsorbent resin powder is preferably from about 5 to 50% by mass based on the total amount of the body fluid leakage preventing agent, and is about 15 to 35 mass%. /. Especially good. -13- 200808173 The body fluid leakage preventing agent of the present invention is added to the above components, and if necessary, may also contain a liquid nonionic surfactant (E) which is heated at room temperature when mixed with water and/or is soluble. The alcoholic organic solvent (F) of water is used as a co-solvent. The liquid nonionic surfactant (E) which is heated at room temperature when mixed with water, which is used in the present invention, may, for example, be a coconut oil fatty acid monoethanolamine or a coconut oil fatty acid diethanolamine 1:1 type. Coconut oil fatty acid diethanol amide 1:2, polyethylene oxide coconut oil fatty acid monoethanol decylamine, lauric acid diethanol amide, polyethylene oxide lauryl ether, polyethylene oxide cetyl ether, Polyethylene oxide higher alcohol ether, polyethylene glycol (average molecular weight of polymerization degree is 600 or less), polyethylene oxide polypropylene oxide ethylene glycol (addition of ethylene oxide to polypropylene Pluronic type non-polypropylene glycol Ionic surfactant), polyethylene oxide alkyl (alkyl group having 12 to 14 carbon atoms), ether (ethylene oxide addition molar number: 7 to 12 moles), etc. A surfactant such as an ethane alkyl ether system, a sorbitan fatty acid ester type, or a polyethylene oxide sorbitan fatty acid ester type may be used alone or in combination of two or more. Among these nonionic surfactants (E), liquid polyethylene glycol (having an average molecular weight of about 200 to 600) is preferred. In addition, strictly speaking, polyethylene glycol can be said to be a precursor of nonionic surfactants, but is classified as a nonionic surfactant in the present specification. However, it is also possible to classify the alcohol-based organic solvent (F) to be described later. These liquid nonionic surfactants (E), especially liquid polyethylene glycol (average molecular weight of polymerization degree is about 200 to 600), can be used as a partial solvent at low temperature (about 30 ° C) ～50° C.) The dispersing stabilizer (B) of the above-mentioned-14-200808173, in particular, the polyepoxide-based thermoplastic sub-type water-absorbent resin powder can be easily dissolved, and when mixed with water, as shown in the following Example 2 When it comes into contact with water, it heats up and the water temperature rises (rises 1 〇 °c~ 'In addition, because it is a surfactant, it is easy to mix and dissolve with water, and it improves the absorption of superabsorbent resin as described above. It is solidified into a solid gel form which is fluid-free, and it is possible to prevent body 〇#, that is, since the absorption of the superabsorbent resin powder (D) tends to increase as the temperature rises, it is caused by the body fluid. The nonionic surfactant (the heat-generating action of E〇 improves the liquid absorption speed of the water-absorbent resin powder (D), rapidly absorbs swelling, and can be solidified into a solid gel form having no fluidity. However, the higher the speed , injected gel and body fluid Since the surface of the contact is solidified into a solid gel having no fluidity, the uniform dispersibility of the highly water-absorbent tree (D) is liable to collapse. Moreover, it becomes easy to leave the gel-like body fluid leakage preventing agent for a long time. Separation. In the hair liquid leakage preventing agent, in the viscous liquid base, the above-mentioned specific stabilizer (B) which is dissolved in the aqueous solution and which is hardly affected by the electrolyte concentration is maintained, and the superabsorbent resin powder (D) is maintained. In view of the above, the nonionic surfactant (E) is preferably about 50% by mass or less, more preferably about 3 to 40% by mass, and more preferably about 5 to 20% by mass, based on the total amount of the body fluid leakage preventing agent. More preferably, the body fluid leakage preventing agent of the present invention is in addition to the above-mentioned nonionic agent (E), a ratio non-dissociation test 12 ° C) which does not impair the efficacy of the present invention, and a water-water velocity liquid. When the leakage water velocity is high, the content of the dispersion of the various substances is higher than that of the liquid body, and the content of the dispersion of the various substances is obtained by the interface, and may also contain an anionic interface depending on the requirements of -15-200808173. The anionic surfactant may, for example, be a poly(ethylene oxide)-based ether sulfate system, polyethylene oxide lauryl ether sulfate, polyethylene oxide lauryl ether sulfate triethanolamine, polycyclic ring. Oxyethane group (alkyl group having 1 to 15 carbon atoms) sodium ether sulfate (addition of ethylene oxide to moles: 3) alkyl group (alkyl group having 11 and 13 carbon atoms) And 15) alkyl ether sulfates such as triethanolamine, sodium alkyl sulfate, alkylethanol sulfate triethanolamine, higher alcohol sodium sulfate, etc.; polyoxyethylene alkyl sulfosuccinate disodium, polyethylene oxide sulfonate a sulfosuccinate salt of succinic acid, polyethylene oxide sulfosuccinate, lauryl disodium, sulfonic acid disodium sulphate, sulfosuccinate, polyethylene oxide, lauryl ethanolamine, disodium, or the like; A surfactant such as an alkylbenzenesulfonic acid group such as sodium dodecylbenzenesulfonate may be used alone or in combination of two or more. The alcohol-based organic solvent (F) can be used as the water-soluble solvent of the above-mentioned nonionic surfactant or polar solvent, and is not particularly limited, and at least one selected from the group consisting of ethylene glycol and propylene glycol can be suitably used. An alcohol-based organic solvent in which diethylene glycol, triethylene glycol, glycerin, methanol, ethanol, and isopropyl alcohol are grouped. Among these alcohol-based organic solvents, glycerin is preferred. Glycerin is easily mixed with water, although there is only a small amount, but the water temperature rises slightly when mixed (about 3 t). Therefore, it is possible to increase the water absorption speed of the super absorbent resin, and to improve the viscosity of the prepared body fluid leakage preventing agent, so that the fluidity is good, and at the low temperature, it helps to prevent the solidification of the oil gel. The content of the alcohol-based organic solvent is preferably about 20% by mass or less based on the total amount of the body fluid leakage preventing agent, and is preferably about 1 to 10% by mass. The body fluid leakage preventing agent of the present invention may further contain at least -16-200808173 one kind of other additives selected from the group consisting of a bactericide, a mildew preservative, a deodorant, and a fragrance, as needed. Examples of the bactericide include isopropyl methyl phenol, chlorhexidine gluconate, thyme acid, o-phenylbenzene, decyl dimethyl benzyl chlorinated, and hexadecanthyl chloride. ( Cety lpyridinium chloride ) , B enzethonium chloride , Triclosan , e - polylysine , Lysozyme chloride , eucalyptus , grapefruit seed extract The pepper extract "Wasaouro" or the like may be used alone or in combination of two or more. Examples of the antifungal and preservative include sodium p-hydroxybenzoate, p-butyl perbenzoate, propyl p-hydroxybenzoate, isobutyl p-hydroxybenzoate, sodium benzoate, sodium propionate, and Thiabendazole. Isothiazolone or the like may be used alone or in combination of two or more. As the deodorant, for example, Meng Zongzhu extract, green tea extract, long-chain betaine compound, persimmon extract, the general name of tannin as the main component of the deodorant, and the plant extracts mixed with the plant extract are particularly deodorized. These may be used alone or in combination of two or more. Further, examples of the flavor include various natural and artificial flavors such as floral notes, root orange notes, fruit notes, wood notes, fresh note, mixed notes, grass notes, and mint notes. Such as the above-mentioned fungicides, mildew preservatives, deodorants and perfumes, to maintain the desired effect of each component, to obtain safety and good economic performance -17- 200808173 point of view on the viscous. The proportion of the body fluid leakage preventing agent as a whole is preferably about 0.001 to 15% by mass, and preferably about 0.003 to 8 mass%, respectively, of the bactericide and the antifungal preservative. Similarly, the deodorant is preferably about 5 to 20% by mass, more preferably about 1 to 10% by mass. Further, the fragrance is preferably about 0.001 to 10% by mass, more preferably about 0.01 to 5% by mass. Others may contain a coloring matter, and the amount of the compounding amount and the color tone are not particularly limited, and may be arbitrarily set. # The viscosity of the body fluid leakage preventing agent of the present invention containing the above components is preferably 6,000 to 50,000 cPs, preferably about 10,00 to 40,000. ? 3 is especially good. In addition, the viscosity system is a viscosity meter ("Viscometer" type: DV-1+, manufactured by Brookfield, Inc., USA), and the motor liquid shaft ( spindle) No. 07, the number of rotations: 20 rpm, and the body fluid leakage prevention agent temperature is used. : The measurement conditions of 20 ° C are measured, but the measurement is not limited thereto, and the measurement may be carried out under the same conditions.

® 另外，因爲上述溶劑（A )或非離子性界面活性劑（E )之含量愈低，因此高吸水性樹脂粉末（D )之含量愈高 、 ，體液漏出防止劑成爲凝膠狀的時間變短，以及液的黏度 /上升，所以可藉由調節此等配合量，調節成爲因應形成凝 膠狀的時間或所需用途（使用部位）之液黏度。 注入本發明之體液漏出防止劑於體腔之充塡量係因應 使用部位而可適當設定，並非特定限定者。另外，雖依油 性凝膠狀之體液漏出防止劑中所含之高吸水性樹脂之吸水 性能而定，具有凝固3,000ml的水成凝膠狀，防止體液自 -18-In addition, since the content of the above-mentioned solvent (A) or the nonionic surfactant (E) is lower, the higher the content of the superabsorbent resin powder (D), the longer the body fluid leakage preventing agent becomes gelatinous. Since it is short and the viscosity/elevation of the liquid is adjusted, it is possible to adjust the liquid viscosity in response to the time required to form a gel or the intended use (use site) by adjusting the amount of the compound. The amount of the body fluid leakage preventing agent to be injected into the body cavity to be injected into the body cavity can be appropriately set depending on the site to be used, and is not particularly limited. In addition, depending on the water absorbing property of the superabsorbent resin contained in the oily gel-like body fluid leakage preventing agent, 3,000 ml of water is solidified into a gel to prevent body fluids from being -18-

200808173 體腔內漏出之吸水能力程度即可，一般係以5〜60g ’以1 0〜40g尤佳。例如自遺體鼻孔注入咽喉部位二 漏出防止劑（含5〜50質量％之高吸水性樹脂）之货 係以約8〜40g爲宜，以1〇〜25g程度尤佳。油性慕 之體液漏出防止劑之注入量過多時，因爲注入器具變 將難以操作，成本變高。另一方面，注入量過少時， 體液難以凝固成凝膠狀，有體液漏出之危險性，所] 宜。 以下係參考附圖下，說明關於適合注入本發明；; 漏出防止劑之遺體處理裝置之各形態之具體例。 圖2〜圖5係表示自鼻孔插入，注入、裝塡上^ 漏出防止劑於咽喉部位用之處理裝置，圖2〜圖4 { 該注入器10，圖5係表示插入管40，符號X係表5 於注入器1 0內之本發明之體液漏出防止劑。 圖2〜圖4係表示該注入器1〇，圖4係表示自0 表示的狀態於中心線周圍旋轉9 0。狀態之斷面圖。多 〜圖4所示，注入器1〇係由皆爲高密度聚乙烯、| 聚醯胺等之塑膠所製作之筒狀主體20及活塞3〇所| 筒狀主體20係由具有先端作爲吐出口部份運作之廷 部份22之圓筒狀零件21，及被覆該外圍之覆蓋零件 形成。 由圖2顯示’覆蓋零件25係斷面成八角形之 係於醫院中護士可容易判別而不會錯認爲一般注射 成，並且，先端部份形成前端略細之圓錐狀，嵌入 爲宜 .體液 :塡量 丨膠狀 :大， 因爲 不適 體液 體液 表不 收納 2所 圖2 酯、 成。 出筒 25所 體， 之構 筒狀 -19- 200808173 零件21時不易脫落之構成。另外，藉由使覆蓋零件著色 ，或著色使該顏色與其他零件顏色相異，形成彩色的注入 器，亦可明顯地掌握使用場所。如圖4明顯顯示，覆蓋零 件25係於該後端部份具有鈎住手指用之突出於半徑方向 外側之一對倒鈎部份2 6。倒鈎部份2 6之先端部份係朝吐 出筒部份22的方向彎曲，手指將容易扣住。進而，於圓 筒狀零件2 1之後端形成一對凸狀停止部份23，構成爲藉 由倒鈎部份26與停止部份23相接觸，手指鈎住倒鈎部份 26進行注入操作時，覆蓋零件25不會往圓筒狀零件21後 端之後方移動。另外，於吐出筒部份22之先端開口部份 係冠上於充塡本發明之體液漏出防止劑於注入器1 0內後 可取下之保護蓋29。另外，於本實施形態中，圓筒狀零件 2 1及覆蓋零件25係分別形成之個體，但亦可一體成形。 另一方面，活塞30係自上述筒狀本體20之圓筒狀零 件2 1之後端部份側自在地滑動地插入。活塞3 0之長度係 爲使可壓出全部內容物之體液漏出防止劑X，設計成比圓 筒狀零件21長度更長。活塞3 〇係具有斷面成十字形之活 塞桿3 1，該先端部份係形成直徑比該活塞桿的斷面尺寸稍 大之圓形凸緣部份3 2。自該圓形凸緣部份3 2突出所形成 凸緣部份33周圍，冠上由合成樹脂或橡膠等所製作之橡 膠墊34。於活塞桿31之後端，使手指容易推壓活塞桿3 1 ，形成接觸手指之圓板狀部份35。活塞30係自後端部份 側插入筒狀主體20之圓筒狀零件21時，以上述橡膠墊34 接觸注入器1 〇之圓筒狀零件2 1內周面之狀態，滑動於圓 -20- 200808173 筒狀零件21內之構成。另外，圓筒狀零件之後端部份 附近之內周面形成向內側稍突出之環狀的突出條狀部份24 ，使活塞桿31之圓形凸緣部份32接觸此突出條狀部份24 ，使活塞30不易自筒狀主體20拔出之構成。另外’於本 實施形態中活塞桿3 1係斷面成十字形，但亦可爲斷面成 圓形等之棒狀。 插入管4 0係插入鼻孔時’沿者鼻腔形狀’具有可携 柔軟性之聚酯彈性體、軟質氯化乙烯樹脂、橡膠等之可撓 性樹脂所製作。如圖5所示，插入管40之先端部份41係 爲使容易自鼻孔插入，形成約半球狀而封閉，並且於該側 面，位置錯開之2個地方，具有互相直行方向之各一對開 孔部份42，並且於後端部份，爲連接上述注入器1 0之吐 出筒部份22，於後側具有稍擴張之圓錐狀之連接部份43 。另外，於自插入管40後端之所定距離（以連接部份43 之先端位置爲宜），如圍繞外圍之半徑方向外側具有突出 之斷面成圓形之制止部份44。 上述插入管40之先端部份之開孔部份42係可形成圓 形、橢圓形等所需形狀的孔，該位置係以距離插入管先端 約5〜30mm爲宜。另外，開孔部份42之數量於本實施形 態爲4個，但可1〜6個程度之任意數。另外，上述制止 部份44係依自插入管主體穿過鼻孔插入咽頭部位時到達 開孔部份42之長度（注入位置）而決定，自插入管40之 先端至制止部份44之長度係以約100〜140mm爲宜，另 外，插入管主體係以外徑約爲3.5〜7mm，內徑約爲2〜 -21 - 200808173 5mm爲宜。 另外，上述實施形態中’插入管4 0之後端部份係與 連接部份43 —體成形，但亦可連接部份43爲不同個體。 此時，連接部份係以剛性合成樹脂形成爲宜，此連接部份 與插入管主體係由黏合劑、焊接等之適當手段接合。另外 ，制止部份44亦可形成於連接部份之先端，或亦可形成 於插入管之後端。另外，亦可自先端部份之所定位置彎曲 插入管主體，自鼻孔插入至咽頭部位深處時，可無阻力順 利地插入。此時，使彎曲的位置係自插入管主體之先端約 22〜45mm，以距離約爲20〜33mm之任意部份爲宜，另外 ，彎曲角度爲〇〜95°，以30〜70°爲宜。 使用上述遺體處理裝置時，首先，取下注入器10之 吐出筒部份22之保護蓋29，嵌合吐出筒部份22於插入管 40之連接部份43，連接插入管40及注入器10。接著，自 鼻孔A(參考圖1)朝向咽喉部位B插入插入管40，當插 入管40之制止部份44接觸鼻尖時停止插入。此時，爲減 輕插入阻力，亦可塗佈潤滑劑於插入管40。接著，推壓注 入器1 0之活塞3 0，使注入器1 0內之凝膠狀之體液漏出防 止劑X經由插入管40注入咽喉部位B。壓出注入器1 0內 之體液漏出防止劑X，充塡後，自鼻孔A拔出注入器10 及插入管4 0。 另外，於上述操作方法中，以連接插入管4 0於注入 器1 〇之狀態，插入於鼻孔A，但亦可以先插入插入管40 於鼻孔A，接著再連接注入器10於插入管40。另外，注 -22 - 200808173 入器1 〇與插入管4 0係可以連接狀態收納於容器中，此時 可自容器取出’ 即進行處理作業。或者亦可於上述實施 形態，注入器1 〇與插入管40係分開個體，但此等亦可爲 製作成一體者。另外’取代插入管4〇所形成之制止部份 44，即使爲記有標記者，可防止插入位置某些程度不齊。 接著，關於注入·裝塡體液漏出防止劑於肛門及/或 陰道用之處理裝置之適合實施形態，參考圖6〜圖8下說 明。 圖6〜圖8係表示注入器i〇a，圖8係表示自圖6所 表示的狀態於中心線周圍旋轉90 °狀態之斷面圖。如圖6 〜圖8所示，於此實施形態中，與上述實施形態同樣地， 注入器l〇a係由皆爲高密度聚乙烯、聚酯、聚醯胺等之塑 膠所製作之筒狀主體20a及活塞30所構成。但是與上述 實施形態相異，於注入器1 0a內，纖維狀充塡材料（栓部 材料）Y與凝膠狀之體液漏出防止劑X —起收納。此纖維 狀充塡材料Y係於肛門或陰道之體腔內，凝膠狀之體液漏 出防止劑X成爲固狀之凝膠後，用以即使體腔各部份之肌 肉死後弛緩，固體狀凝膠之間發生空隙，仍可確實地達成 防止體液漏出者，但收納物亦可僅爲凝膠狀之體液漏出防 止劑X。一個裝置所收納之體液漏出防止劑X (含5〜5 0 質量％之高吸水性樹脂）之量約爲1〜l〇g，以約1〜5g爲 宜，纖維狀充塡材料Y係以設定長度約爲10〜30mm，直 徑約爲8〜23mm之範圍內爲宜。 筒狀主體20a係由於先端具有吐出口部份22a之圓筒 -23- 200808173 狀零件2 1 a，及被覆該外圍之覆蓋零件2 5 a所形成。圓筒 狀零件21a先端之吐出口部份22a係向著半徑方向中心， 向外側彎曲，藉由沿線存在之多數個舌片2 8而形成約半 球狀，以及由該多數舌片28之先端部份之開口與舌片間 空隙形成開口部份。各舌片2 8係具有可彎向外側之柔軟 性。另外，死後至僵直間，插入外徑大之筒狀注入器（ syringe)於肛門或陰道時，因爲肛門管或陰道口張大，至 收縮需要時間，所以成爲體液漏出的原因。另外，圓筒狀 零件21a之外徑細而容易插入，使用簡便。因此，設定圓 筒狀零件2 1 a之外徑約爲1 0〜2 5 mm，以約1 〇〜1 5 mm尤 佳，內徑約爲8〜23mm之範圍內爲宜。 覆蓋零件25a係如圖6所示之斷面成八角形之筒體， 係於醫院中護士可容易判別而不會錯認爲一般注射器之構 成。另外，藉由使覆蓋零件著色，或著色使該顏色與其他 零件顏色相異，形成彩色的注入器 <，亦可明顯地掌握使用 場所。如圖8明顯顯示，於上述圓筒狀零件2 1 a之後端部 份設置用以鈎住手指之突出於半徑方向外側之一對倒鈎部 份2 6，另一方面，覆蓋零件2 5 a係於該先端部份具有向後 方展開之傘狀制止部份2 7。自圓筒狀零件2 1 a之先端至制 止部份27之距離係設定於約15〜50mm之範圍內爲宜， 制止部份27距離圓筒狀零件2 1 a之外周面之高度係以設 定於容易停止於肛門或陰道口之約5〜30mm之範圍內爲 宜。另外，制止部份27並不一定如本實施形態之成爲傘 狀，只要可確保進行僅插入注入器1 0於肛門或陰道所定 -24- 200808173 長度之插入位置，不超過其以上之零件或標記即可， 可爲圓板狀，或視覺上可容易確認標記。另外，倒鈎 2 6之先端部份係係朝吐出筒部份2 2 a的方向彎曲，手 容易扣住。倒鈎部份26距離圓筒狀零件2 1 a外周面 度約爲5〜1 8mm，先端部份之彎曲程度係以設定於〇 之範圍內爲宜。另外，使用如此覆蓋零件時，上述倒 份與制止部份係可設置於覆蓋零件之所定位置，但以 實施形態，制止部份係設置於覆蓋零件之先端部份或 零件與圓筒狀零件爲相同長度時於略中間部份，倒鈎 係設置於圓筒狀零件之後端部份爲宜。 另外，圓筒狀零件2 1 a之後端係形成連接於上述 倒鈎部份26，突出於側面之一對凸狀停止部份23a， 零件25a係構成爲藉由接觸此停止部份23a及倒鈎部 ’手指鈎住倒鈎部份26進行注入操作時，覆蓋零件 不會往圓筒狀零件21a後端之後方移動。另外，於圓 零件2 1 a之先端部份係冠上於充塡本發明之體液漏出 劑於注入器10內後可取下之保護蓋29a。另外，於本 形態中，圓筒狀零件21a及覆蓋零件25a係分別形成 體，但亦可一體成形。 另一方面，活塞3 0之構造係與上述實施形態相 於上述筒狀本體20a之圓筒狀零件21a之後端部份側 滑動地插入。爲可壓出內容物之體液漏出防止劑X及 充塡材料γ，活塞3 0之長度係設計成比圓筒狀零件 長度更長。活塞30係具有斷面成十字形之活塞桿31 例如 I部份 •指將 丨之高 〜50。 1鈎部 如本 覆蓋 部份 一對 覆蓋 份2 6 25a 筒狀 防止 實施 之個 同， 自在 纖維 2 1a ，該 -25- 200808173 先端部份係形成直徑比活塞桿的斷面尺寸稍大之圓形凸緣 部份32。自該圓形凸緣部份32突出所形成凸緣部份33周 圍，冠上由合成樹脂或橡膠等所製作之橡膠墊34。另外， 於活塞桿31之後端，使手指容易推壓活塞桿31，形成接 觸手指之圓板狀部份3 5。 活塞30係自後端部份側插入筒狀主體20之圓筒狀零 件2 1 a時，以上述橡膠墊3 4接觸注入器1 0之圓筒狀零件 2 1 a內周面之狀態，滑動於圓筒狀零件2 1 a內之構成。另 外’圓筒狀零件2 1 a之後端部份附近之內周面形成向內側 稍突出之環狀之突出條狀部份24，使活塞桿3 1之圓形凸 緣部份32接觸此突出條狀部份24，使活塞30不易自筒狀 主體2 0拔出之構成。另外，於本實施形態中活塞桿3 1係 斷面成.十字形，但亦可爲斷面成圓形等之棒狀。 使用注入·裝塡上述體液漏出防止劑X及纖維充塡材 料Y用之處理裝置時，首先，取下注入器10a之吐出筒部 份22a之保護蓋29a，直接插入例如肛門或陰道，制止部 份27接觸肛門或陰道之外部時停止插入。此時，爲減輕 插入抵抗，亦可塗佈潤滑劑於保護蓋29a。接著，推壓注 入器l〇a之活塞30，與保護蓋29a同時注入注入器i〇a內 之凝膠狀體液漏出防止劑X及纖維充塡材料Y。此時，吸 收體液及污物中之液體之體液漏出防止劑X中之高吸水性 樹脂粉末膨脹，並且該部份滲透於纖維充塡材料γ，因爲 形成固體狀凝膠，所以可有效地防止體及污物漏出。之後 ’自肛門或陰道拔出注入器1 0 a。 -26- 200808173 上述纖維充塡材料γ係可由高吸水性樹脂纖維之不織 物、壓縮紙漿紙、綿、綿及高吸水性樹脂纖維混紡、高吸 水性樹脂纖維等之成形物、合成纖維之不織布、布等形成 ，但尤其以使用水膨潤性纖維，例如丙烯酸纖維之內層及 吸水性樹脂所形成之外層所構成之東洋紡績股份有限公司 製之LAN SEAL (註冊商標）F或LAN SEAL (註冊商標） K成形成圓柱形者，或壓縮成形紙漿成圓柱形者（例：女 性用衛生棉條型）爲宜。 如上述之自鼻孔插入，注入、裝塡體液漏出防止劑於 咽喉部份用之處理裝置、及注入、裝塡體液漏出防止劑於 肛門及/或陰道用之處理裝置，與防止自耳孔及/或鼻孔漏 出體液用之纖維製封閉材料、或另外口中裝塡用之纖維製 封閉材料一同收納於一個容器內，構成爲遺體處理裝置單 元爲宜，因此而攜帶方便，可迅速地進行遺體處理。 作爲防止自耳孔及/或鼻孔漏出體液用之纖維製封閉 材料’可適合使用由綿、高吸水性樹脂纖維、綿及高吸水 性樹脂纖維之混紡及不織物所形成，成形成球形、柱狀、 立方體等所需的形狀者。以備有耳栓用2個及鼻栓用2個 之封閉材料爲宜。 力外’口中裝境用之纖維製封閉材料係放入臉頼內， 以防止體液漏出及形成臉頰膨起近似於自然膨起爲目的者 ’可適合使用如上述之綿、綿及高吸水性樹脂纖維混紡、 高吸性樹脂纖維等之布或不織物、或棉及高吸性樹脂纖維 之不織物之單品材料、或將此等單品材料以任意之層結構 27- 200808173 層合成三明治狀之材料所成之封閉材料。 參考附圖下進行說明以上之適合注入本發明之體液漏 出防止劑之遺體處理裝置之各種形態，但本發明之油性凝 膠狀之體液漏出防止劑亦可由傳統已知之注入器注入·裝 塡於遺體之口、鼻、耳、肛門、女性之陰道等之體腔，封 閉液體，當然不侷限於上述各形態者。 【實施方式】 〔實施例〕 以下係表示具體地確認本發明之體液漏出防止劑之功 效之實施例及試驗例，但當然本發明並非侷限於如下之實 施例者。 實施例1〜5及比較例1 以表1所示之處方及配合比率，使溶解分散安定劑、 增黏劑及其他添加劑於醚系溶劑（sunfineDM - 200 )之黏 稠溶液中，於攪拌下緩緩地加入規定量之高吸水性樹脂粉 末，調製使高吸水性樹脂粉末均勻分散之油性凝膠狀體液 漏出防止劑（實施例1〜5 )。另外，用以比較，溶解作爲 凝膠化劑之丙烯酸聚合物（羧乙烯基聚合物之鹼金屬鹽） 於醇系溶劑之乙二醇之液，使高吸水性樹脂粉末均勻地分 散，調製體液漏出防止劑（比較例1)。 如此調製之體液漏出防止劑之吸水速度係由下述之試 驗方法比較。 -28- 200808173 試驗例1 (試驗試樣之吸水速度試驗） 試驗方法= 於100ml之燒杯，放入秤量lg之試驗試樣，接著穩 定地注入80ml之離子交換水（20°C )，測定全部離子交 換水成爲凝膠狀之時間。 試驗結果係合倂如表1所示。200808173 The degree of water absorption in the body cavity can be as much as possible, generally 5 to 60 g' is preferably 10 to 40 g. For example, it is preferable that the intestine is injected into the throat portion and the leakage preventing agent (containing 5 to 50% by mass of the highly water-absorbent resin) is preferably about 8 to 40 g, more preferably 1 to 25 g. When the amount of the body fluid leakage preventing agent of the oily substance is too large, the injection device becomes difficult to handle, and the cost becomes high. On the other hand, when the amount of the injection is too small, it is difficult for the body fluid to solidify into a gel form, and there is a risk that the body fluid leaks out. Hereinafter, specific examples of respective forms of the body treatment apparatus for the leakage prevention agent will be described with reference to the accompanying drawings. Fig. 2 to Fig. 5 show a processing device for inserting, injecting, and smearing the leakage preventing agent into the throat portion, and Fig. 2 to Fig. 4 {the injector 10, Fig. 5 showing the insertion tube 40, symbol X Table 5 The body fluid leakage preventing agent of the present invention in the injector 10. 2 to 4 show the injector 1A, and Fig. 4 shows a state rotated from 0 to 0 around the center line. A sectional view of the state. As shown in Fig. 4, the injector 1 is a cylindrical body 20 and a piston 3 made of plastic such as high-density polyethylene and polyamide. The cylindrical body 20 has a tip end as a spit. The cylindrical part 21 of the portion 22 of the outlet portion of the outlet is formed, and the covering member covering the periphery is formed. Figure 2 shows that the cover part 25 is a octagonal section that can be easily identified by the nurse in the hospital without being mistaken for general injection, and the apex portion is formed into a slightly tapered conical shape, which is suitable for embedding. Body fluid: 塡 丨 状 :: large, because the body fluid does not contain 2 of the Figure 2 ester, into. The body of the cylinder is 25, and the structure is cylindrical. -19- 200808173 The component 21 is not easy to fall off. Further, by coloring the cover member or coloring the color to be different from the color of the other parts to form a color injector, the use place can be clearly grasped. As is apparent from Fig. 4, the cover member 25 is attached to the rear end portion of the pair of barb portions 26 which protrude from the finger in the radial direction. The tip end portion of the barb portion 26 is bent in the direction of the discharge cylinder portion 22, and the fingers are easily caught. Further, a pair of convex stop portions 23 are formed at the rear end of the cylindrical member 2 1 so as to be in contact with the stop portion 23 by the barb portion 26, and the finger hooks the barb portion 26 for the injection operation. The cover member 25 does not move to the rear of the rear end of the cylindrical member 21. Further, the opening end portion of the discharge cylinder portion 22 is attached to the protective cover 29 which is filled in the injector 10 after the body fluid leakage preventing agent of the present invention is filled. Further, in the present embodiment, the cylindrical member 21 and the covering member 25 are formed separately, but they may be integrally formed. On the other hand, the piston 30 is slidably inserted from the rear end portion of the cylindrical member 2 of the cylindrical body 20. The length of the piston 30 is designed to make the body fluid leakage preventing agent X capable of pressing out the entire contents, and is designed to be longer than the length of the cylindrical member 21. The piston 3 has a cross-shaped piston rod 3 1, and the tip end portion is formed with a circular flange portion 3 2 having a diameter slightly larger than the cross-sectional dimension of the piston rod. A rubber pad 34 made of synthetic resin, rubber or the like is crowned from the periphery of the flange portion 33 formed by the circular flange portion 32. At the rear end of the piston rod 31, the finger is easily pushed against the piston rod 3 1 to form a disc-shaped portion 35 that contacts the finger. When the piston 30 is inserted into the cylindrical member 21 of the cylindrical body 20 from the rear end side, the rubber pad 34 is in contact with the inner peripheral surface of the cylindrical member 2 1 of the injector 1 and is slid in the circle -20. - 200808173 The structure of the cylindrical part 21. Further, the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member forms an annular projecting strip portion 24 slightly protruding inwardly, so that the circular flange portion 32 of the piston rod 31 contacts the protruding strip portion. 24, the piston 30 is not easily pulled out from the tubular body 20. Further, in the present embodiment, the piston rod 3 1 has a cross section, but may have a rod shape such as a circular cross section. The insertion tube 40 is made of a flexible resin such as a polyester elastomer, a soft vinyl chloride resin or a rubber which is "portable in the shape of the nose" when it is inserted into the nostril. As shown in Fig. 5, the distal end portion 41 of the insertion tube 40 is formed so as to be easily inserted from the nostril, formed into a hemispherical shape, and closed at two positions on the side surface, and has a pair of openings in the straight direction. The portion 42, and at the rear end portion, is a discharge tube portion 22 that connects the injector 10, and has a slightly expanded conical connection portion 43 on the rear side. Further, a predetermined distance from the rear end of the insertion tube 40 (preferably at the tip end position of the connecting portion 43) is formed such that the outer peripheral portion of the outer peripheral portion has a convex portion 44 having a circular cross section. The opening portion 42 of the tip end portion of the insertion tube 40 is formed into a hole having a desired shape such as a circular shape or an elliptical shape, and the position is preferably about 5 to 30 mm from the tip end of the insertion tube. Further, the number of the opening portions 42 is four in this embodiment, but may be any number from 1 to 6. Further, the stopper portion 44 is determined by the length (injection position) of the insertion portion 42 when the insertion tube main body is inserted into the pharyngeal portion through the nostril, and the length from the tip end of the insertion tube 40 to the stopper portion 44 is Preferably, the main pipe system has an outer diameter of about 3.5 to 7 mm and an inner diameter of about 2 to -21 - 200808173 5 mm. Further, in the above embodiment, the end portion of the insertion tube 40 is formed integrally with the connecting portion 43, but the connecting portion 43 may be a different individual. In this case, the connecting portion is preferably formed of a rigid synthetic resin which is joined to the main system of the insertion tube by an appropriate means such as a bonding agent, welding or the like. Alternatively, the restraining portion 44 may be formed at the tip end of the connecting portion or may be formed at the rear end of the insertion tube. Alternatively, the tube body can be bent from the predetermined position of the apex portion, and can be smoothly inserted without resistance when inserted from the nostril to the deep part of the pharyngeal portion. At this time, the position of the bending is about 22 to 45 mm from the tip end of the insertion tube body, and any portion having a distance of about 20 to 33 mm is preferable, and the bending angle is 〇~95°, preferably 30 to 70°. . When the above-described body treatment device is used, first, the protective cover 29 of the discharge cylinder portion 22 of the injector 10 is removed, and the connection portion 43 of the discharge tube portion 22 is inserted into the insertion tube 40, and the insertion tube 40 and the injector 10 are connected. . Next, the insertion tube 40 is inserted from the nostril A (refer to Fig. 1) toward the throat portion B, and the insertion is stopped when the restraining portion 44 of the insertion tube 40 contacts the tip of the nose. At this time, in order to reduce the insertion resistance, a lubricant may be applied to the insertion tube 40. Next, the piston 30 of the injector 10 is pushed, and the gel-like body fluid in the injector 10 is leaked out of the inhibitor X into the throat portion B via the insertion tube 40. The body fluid leakage preventing agent X in the injector 10 is pushed out, and after filling, the injector 10 and the insertion tube 40 are pulled out from the nostril A. Further, in the above operation method, the insertion tube 40 is inserted into the nostril A in a state in which the insertion tube 40 is inserted, but the insertion tube 40 may be inserted into the nostril A first, and then the injector 10 may be connected to the insertion tube 40. In addition, Note -22 - 200808173 The inlet 1 〇 and the insertion tube 40 are detachably stored in the container, and the container can be taken out from the container. Alternatively, in the above embodiment, the injector 1 is separated from the insertion tube 40, but these may be made in one piece. Further, the stopper portion 44 formed by the replacement of the insertion tube 4 , can prevent the insertion position from being uneven to some extent even if it is marked. Next, a suitable embodiment of the treatment device for injecting and squeezing the body fluid leakage preventing agent into the anus and/or the vagina will be described with reference to Figs. 6 to 8 . Fig. 6 to Fig. 8 show an injector i 〇 a, and Fig. 8 is a cross-sectional view showing a state in which the state shown in Fig. 6 is rotated by 90 ° around the center line. As shown in Fig. 6 to Fig. 8, in the embodiment, as in the above embodiment, the injector 10a is made of a plastic made of high-density polyethylene, polyester, polyamide or the like. The main body 20a and the piston 30 are formed. However, in the injector 10a, the fibrous filling material (plug material) Y is housed together with the gel-like body fluid leakage preventing agent X. The fibrous filling material Y is in the body cavity of the anus or the vagina, and the gel-like body fluid leakage preventing agent X becomes a solid gel, and is used to relax even after the muscles of various parts of the body cavity are dead, and the solid gel is used. When a void occurs, it is possible to surely prevent leakage of body fluid, but the storage may be only a gel-like body fluid leakage preventing agent X. The amount of the body fluid leakage preventing agent X (containing 5 to 50% by mass of the highly water-absorbent resin) contained in one device is about 1 to 10 g, preferably about 1 to 5 g, and the fibrous filling material Y is It is preferable to set the length to be about 10 to 30 mm and the diameter to be about 8 to 23 mm. The cylindrical body 20a is formed by a cylindrical member -23-200808173-shaped member 2 1 a having a discharge port portion 22a at the tip end, and a covering member 2 5 a covering the periphery. The discharge port portion 22a at the tip end of the cylindrical member 21a is bent toward the center in the radial direction, and is formed into a hemispherical shape by a plurality of tongues 28 existing along the line, and a tip end portion of the plurality of tongue pieces 28 The opening and the gap between the tongues form an opening portion. Each of the tongues 28 has a flexibility to bend outward. In addition, between the post-mortem and the stiffness, when a syringe having a large outer diameter is inserted into the anus or the vagina, the anal canal or the vaginal opening is enlarged, and it takes time to contract, so that it is a cause of leakage of body fluid. Further, the cylindrical member 21a has a small outer diameter and is easy to insert, and is easy to use. Therefore, it is preferable that the outer diameter of the cylindrical member 2 1 a is about 10 to 2 5 mm, preferably about 1 〇 to 15 mm, and the inner diameter is about 8 to 23 mm. The covering member 25a is a cylindrical body having an octagonal cross section as shown in Fig. 6. It can be easily discriminated by a nurse in a hospital without erroneously thinking that the general syringe is constructed. Further, by coloring the cover member or coloring the color to be different from the color of the other parts to form a color injector, the use place can be clearly grasped. As is apparent from Fig. 8, the rear end portion of the cylindrical member 2 1 a is provided with a pair of barb portions 2 6 for hooking the finger to protrude from the outer side in the radial direction. On the other hand, the cover member 2 5 a The apex portion has an umbrella-shaped stop portion 27 that is deployed rearward. It is preferable that the distance from the tip end of the cylindrical member 2 1 a to the stopper portion 27 is set to be in the range of about 15 to 50 mm, and the height of the peripheral portion of the cylindrical portion 2 1 a is set by the stopper portion 27 to be set. It is preferable to stop in the range of about 5 to 30 mm which is easy to stop at the anus or vaginal opening. Further, the restraining portion 27 does not necessarily have an umbrella shape as in the present embodiment, as long as it can be ensured that only the insertion position of the injector 10 in the length of the anus or the vagina is -24-200808173, and the part or the mark which is not more than the above is inserted. Yes, it can be round, or visually easy to confirm the mark. Further, the tip end portion of the barbs 26 is bent in the direction of the discharge tube portion 2 2 a, and the hand is easily caught. The barb portion 26 is approximately 5 to 18 mm from the outer peripheral surface of the cylindrical member 2 1 a, and the degree of bending of the tip end portion is preferably set within the range of 〇. In addition, when the cover member is used, the inverted portion and the restraining portion may be disposed at a predetermined position of the covering member, but in the embodiment, the stopping portion is disposed at the tip end portion of the covering member or the part and the cylindrical member are When the same length is in the middle portion, the barb is preferably disposed at the rear end portion of the cylindrical member. Further, the rear end of the cylindrical member 2 1 a is formed to be connected to the barb portion 26 and protrudes from one of the side faces to the convex stop portion 23a, and the part 25a is configured to contact the stop portion 23a and fall. When the hook portion 'finger hooks the barb portion 26 to perform the injection operation, the covering member does not move to the rear end of the cylindrical member 21a. Further, the tip end portion of the round member 2 1 a is crowned with a protective cover 29a which can be removed after filling the body fluid leakage agent of the present invention into the injector 10. Further, in the present embodiment, the cylindrical member 21a and the covering member 25a are formed separately, but they may be integrally formed. On the other hand, the structure of the piston 30 is slidably inserted into the rear end portion side of the cylindrical member 21a of the cylindrical body 20a in the above embodiment. The body fluid leakage preventing agent X and the filling material γ can be extruded, and the length of the piston 30 is designed to be longer than the length of the cylindrical member. The piston 30 has a piston rod 31 having a cross-shaped cross section, for example, a portion I/finger. 1 The hook portion is the same as the cover portion of the cover portion 2 6 25a. The self-contained fiber 2 1a, the -25-200808173 tip portion is formed into a circle having a diameter slightly larger than the cross-sectional dimension of the piston rod. Flange portion 32. The circular flange portion 32 protrudes around the flange portion 33 formed, and a rubber pad 34 made of synthetic resin or rubber or the like is crowned. Further, at the rear end of the piston rod 31, the finger is easily pushed against the piston rod 31 to form a disc-shaped portion 35 which contacts the finger. When the piston 30 is inserted into the cylindrical member 2 1 a of the cylindrical body 20 from the side of the rear end portion, the rubber pad 34 contacts the inner peripheral surface of the cylindrical member 2 1 a of the injector 10 and slides. The structure of the cylindrical part 2 1 a. Further, the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 2 1 a forms an annular projecting strip portion 24 slightly protruding inwardly, so that the circular flange portion 32 of the piston rod 31 contacts the projection. The strip portion 24 is configured such that the piston 30 is not easily pulled out from the tubular body 20. Further, in the present embodiment, the piston rod 3 1 has a cross section, but may have a rod shape such as a circular cross section. When the treatment device for injecting and disposing the body fluid leakage preventing agent X and the fiber filling material Y is used, first, the protective cover 29a of the discharge tube portion 22a of the injector 10a is removed, and directly inserted into, for example, the anus or the vagina, and the stopping portion is directly inserted. When the part 27 touches the outside of the anus or vagina, the insertion is stopped. At this time, in order to reduce the insertion resistance, a lubricant may be applied to the protective cover 29a. Then, the piston 30 of the injector l〇a is pressed, and the gel-like body fluid leakage preventing agent X and the fiber-filling material Y in the injector i〇a are simultaneously injected into the protective cover 29a. At this time, the superabsorbent resin powder in the body fluid leakage preventing agent X which absorbs the body fluid and the liquid in the soil is swollen, and the portion penetrates into the fiber-filled material γ, because the solid gel is formed, so that it can be effectively prevented Body and dirt leaked out. Then remove the injector 10 a from the anus or vagina. -26- 200808173 The above-mentioned fiber-filled material γ is a non-woven fabric of a non-absorbent resin fiber, a compressed pulp paper, a cotton, a cotton and a super absorbent resin fiber, a super absorbent resin fiber, and a synthetic fiber. , such as cloth, etc., but in particular, LAN SEAL (registered trademark) F or LAN SEAL (registered by Toyobo Co., Ltd.) made of water swellable fiber, for example, an inner layer of acrylic fiber and a water-absorbent resin. The trademark K) is formed into a cylindrical shape, or a compression-formed pulp is formed into a cylindrical shape (for example, a tampon type for women). Such as the above-mentioned treatment from the nostril, the treatment device for injecting and squeezing the body fluid leakage preventing agent in the throat portion, and the treatment device for injecting and squeezing the body fluid leakage preventing agent into the anus and/or the vagina, and preventing the self-ear hole and/or Or the fibrous sealing material for leaking body fluids in the nostrils or the fibrous sealing material for the other in the mouth is stored in a container, and it is suitable for the body processing device unit, so that it is convenient to carry and can be quickly processed. The fiber-made sealing material for preventing leakage of body fluid from the ear hole and/or the nostril can be suitably formed by blending and non-woven fabric of cotton, super absorbent resin fiber, cotton and super absorbent resin fiber to form a spherical or columnar shape. , cubes, etc. It is preferable to use two sealing materials for the ear plug and two sealing materials for the nasal plug. The external fiber-sealing material used in the mouth is placed in the face to prevent leakage of body fluid and to form a cheek swelling similar to the natural swelling. It is suitable for use in the above-mentioned cotton, cotton and high water absorption. Resin-fiber blended, high-absorbent resin fiber or the like, or non-woven fabric, or cotton or high-absorbent resin fiber, non-woven material, or composite material of any single layer material in any layer structure 27-200808173 A closed material made of a material. The various embodiments of the body treatment apparatus suitable for injecting the body fluid leakage prevention agent of the present invention are described below with reference to the accompanying drawings. However, the oily gel-like body fluid leakage prevention agent of the present invention can also be injected and mounted by a conventionally known injector. The body cavity of the body of the body, the nose, the ear, the anus, the vagina of the woman, etc., the liquid is closed, of course, not limited to the above various forms. [Embodiment] [Examples] The following are examples and test examples for specifically confirming the effects of the body fluid leakage preventing agent of the present invention, but the present invention is of course not limited to the following examples. Examples 1 to 5 and Comparative Example 1 In the viscous solution of the ether solvent (sunfine DM-200), the dissolving and dispersing stabilizer, the tackifier and other additives were dissolved in a viscous solution of the solvent (sunfine DM-200) at the point shown in Table 1 and the mixing ratio. A predetermined amount of the superabsorbent resin powder was gradually added to prepare an oily gel-like body fluid leakage preventing agent (Examples 1 to 5) in which the superabsorbent resin powder was uniformly dispersed. Further, for comparison, a solution of an acrylic polymer (an alkali metal salt of a carboxyvinyl polymer) as a gelling agent in an ethylene glycol solvent is dissolved, and the superabsorbent resin powder is uniformly dispersed to prepare a body fluid. Leakage prevention agent (Comparative Example 1). The water absorption speed of the body fluid leakage preventing agent thus prepared is compared by the following test methods. -28- 200808173 Test Example 1 (Water absorption speed test of test sample) Test method = In a 100 ml beaker, put a test sample weighing lg, and then inject 80 ml of ion-exchanged water (20 ° C) stably, and measure all. The time when the ion-exchanged water becomes a gel. The test results are shown in Table 1.

-29- 200808173 〔表1〕 試驗試樣No· mm%) 實施例No. 比較例 1 1 2 3 4 5 處 方 Sunfine DM-200*1 70 60 60 69 59 乙二醇 • - 79.4 羧乙烯基聚合物巧 • 一 讎 0.2 三乙醇胺 • • • 一 0.4 PEG-200*3 • 10 • SANNONIC SS-120*4 10 10 高吸水性樹脂粉末*5 25 25 25 25 25 20 熱可塑性非離子型吸 水性樹脂*6 5 5 5 5 5 - 乙基纖維素〃 (約49%乙氧基） - - - 1 1 - ㈡日1 100 100 100 100 100 100 結 果 形成至凝膠狀之時間（秒） (3次平均値） 65 58 97 74 118 510 備 考 n SimfineDM-200 :三洋化成工業(股)製之聚環氧乙烷二甲基醚 2羧乙烯基聚合物：商品名「Hibiswako」和光純藥工業(股)製 *3 PEG-2〇0 :平均分子量約爲2〇〇之聚乙二醇 M SANNONIC SS-120 :三洋化成工業(股)製之非離子界面活性劑， ^ 聚環氧乙烷烷基醚 局吸水性樹脂粉末：商品名「Aquakeep」住友精化(股)製 『熱可塑性非離子型吸水性樹脂：商品名「Aquacok」住友精化(股)製 ”乙基纖維素(約49%之乙氧基）··和光純藥工業(股嵐藥 由上述表1顯示結果可知使用醇系基劑之比較例1時 ’調製體液漏出防止劑亦需要長時間，作業性差。相對於 此’於本發明之實施例1〜5中，即使增多高吸水劑樹脂 粉末之添加量’長期間放置時之分散安定性優異，另外， 與比較例1相比較’即使稍增多高吸水劑樹脂粉末之添加 量’可大幅地縮短離子交換水整體形成至凝膠狀之時間。 -30 - 200808173 由此可知，本發明之體液漏出防止劑係迅速地凝固成無流 動性之固體凝膠狀，最適合作爲達成防止體液漏出之體液 漏出防止劑。 另外，上述各實施例使用之聚環氧乙烷二甲基醚（ sunfineDM— 200 )，因爲係無黏度、輕快流動之液狀，與 水容易混合，所以認爲高吸水性樹脂粉末係容易吸水者。 但是，由注入器壓入時，有溶劑先出來，難以注入之傾向 ，所以爲使組成物具有黏性，所以以如實施例2、3添加 PEG (聚乙二醇）一2 00、S ANN ON IC SS - 120，如實施例 4、5添加乙基纖維素等之增黏劑爲宜。 SANNONIC SS — 120 (聚環氧乙烷烷基醚）係溶解乙 基纖維素（約49 %之乙氧基）而增黏。乙基纖維素係增加 乙氧基之取代度時，變得可溶解於無極性溶劑，難溶於極 性溶劑。通常，乙氧基取代43〜5 0%者溶解於無極性溶劑 。如上述實施例4，添加1 %之乙基纖維素時，吸水速度快 ，安定性亦良好，可調製即使長時間放置亦不分離之理想 的油性凝膠狀體液漏出防止劑。但是因爲添加多量的乙基 纖維素時，吸水速度有變差之傾向，所以如上述各實例之 處方時，乙基纖維素之添加量係以0.2〜5 %爲宜，以0.5 〜1 .5%尤佳。另外，溶解乙基纖維素於SANNONIC SS -1 20而增黏之溶液時，添加具有極性之溶劑時，因爲分離 而難以形成凝膠狀，所以於此種組合時，以避免添加極性 溶劑爲宜。另外，如實施例5，溶解乙基纖維素於 SANNONIC SS- 120而增黏之溶液中，添力口非離子界面活 -31 - 200808173 性劑時，吸水速度雖稍慢，但凝膠狀物之滑動良好，順利 地注入·充塡於體腔。 實施例6〜1 0 以表2所示之處方及配合比率，調製使高吸水性樹脂 粉末均勻分散之油性凝膠狀體液漏出防止劑。 如此調製之體液漏出防止劑之吸水速度係與上述試驗 例1同樣地試驗。試驗結果係合倂如表2所示。 〔表2〕 試驗試樣No. (質量％) _例价· 6 7 8 9 10 處 方 Sunfme DM-200*1 69.8 68.8 67.8 57.8 58.8 PEG-200*2 曝 • - 10 - SANNONIC SS-120*3 垂 - 10 高吸水性樹脂粉末*4 25 25 25 25 25 熱可塑性非離子型吸水性樹脂*5 5 6 7 7 6 Viscoster 50K*7 0.2 0.2 0.2 0.2 0.2 合H 100 100 100 100 100 結 果 形成至凝膠狀之時間（秒） (3次之平均働 42 56 65 86 118 備 考 n Sunfme DM-200 ··三洋化成工業(股)製之聚環氧乙烷二甲基醚 *2 PEG-200 :平均分子量約爲200之聚乙二醇 *3 SANNONIC SS-120 :三洋化成工業(股)製之非離子界面活性劑， 聚環氧乙烷烷基醚 %高吸水性樹脂粉末：商品名「Aquakeep」住友精化(股)製 *5熱可塑性非離子型吸水性樹脂：商品名「Aquacok」住友精化(股)製 *6乙基纖維素(約49%之乙氧基）··和光純藥工業(股)試藥 *7 Viscoster 50K :三井化學Polyurethane(股)製增黏劑(聚胺基甲酸乙酯樹脂） -32· 200808173 於實施例6〜10中’作爲增黏劑添加之viscoster — 50K (粉末）係溶解於醚系溶劑（sunfineDM — 200)而增 黏，成爲黏稠液。另外，Vis coster - 5 0K (粉末）亦容易 溶解於水，成爲黏稠液。因此，Viscoster — 5 0K (粉末） 係作爲醚系溶劑之增黏劑最優異的原料。但是添加多量於 油性凝膠狀物之處方時，有容易成凝聚狀態之傾向，因爲 以注入器之注入變得困難，所以如上述實施例之處方時， Viscoster — 50K (粉末）之添加量係以 〇.1〜6%爲宜，以 0 · 1〜2 %尤佳。另外，如實施例8、9增加熱可塑性非離子 型吸水性樹脂之添加量時，油性凝膠狀物之黏性變佳，對 注入器之充塡性亦變佳。但是，添加多量之熱可塑性非離 子型吸水性樹脂時，油性凝膠狀物之黏性雖然增大，但因 爲吸水速度有稍微漸漸變差之傾向，所以添加多量並不適 宜。另外，如實施例9，添加少量之P E G — 2 0 0時，油性 凝膠狀物變得柔軟，充塡變得順利。然而，因爲成爲黏稠 液，所以吸水速度有變差之傾向，添加多量並不適宜。同 樣地，如實施例1〇，添加非離子界面活性劑（SANNONIC SS- 120 )時，因爲有吸水速度變差之傾向，所以添加多 量並不適宜。 實施例1 1〜1 7 以表3所示之處方及配合比率，調製使高吸水性樹脂 粉末均勻分散之油性凝膠狀體液漏出防止劑。所得之油性 凝膠狀體液漏出防止劑具有優異的吸水速度。 -33- 200808173 〔表3〕 試驗試樣No· 實施例No. (質量％) 11 12 13 14 15 16 17 Sunfine DM-200*1 68 67 67 - • - IONET DL-200*2 - • • 68 68 - 鋒 IONET DO-400*3 • 讎 • 68 68 處 高吸水性樹脂粉末M 25 25 25 25 25 25 25 方 熱可塑性非離子型吸水性樹脂％ 6 6 6 • • 祕 聚環氧乙烷％ 1 - 一 • 一 - 聚乙烯基甲基醚 2 晒 7 丨 7 • 乙基纖維素7 (約49%之乙氧基） - - 2 - 7 - 7 合言- 100 100 100 100 100 100 100 ” SimfmeDM-200 :三洋化成工業服)製之聚環氧乙烷二甲基醚 40NETDL-200 :三洋化成工業(股)製之聚環氧乙烷脂肪酸二酯 (別名聚乙二醇二月桂酸酯） 備>3IONETDO-400 :三洋化成工業(股)製之聚環氧乙烷脂肪酸二酯 考 （別名聚乙二醇二油酸酯） M高吸水性樹脂粉末：商品名「Aquakeep」住友精化(股)製 %熱可塑性非離子型吸水性樹脂:商品名「Aquacok」住友精化(股)製 %聚環氧乙烷：商品名(PEO)住友精化(股)製 ”乙基纖維素(約49%之乙氧基）：和光純藥工業(股)試藥 實施例18〜22 放入定量的醚系溶劑（sunfineDM— 200 )及PEG — 200於燒杯中，於攪拌下，投入一定量之下述表4所示之 各分散定劑於其中，加熱（依分散安定劑選擇任意的溫度 )溶解後，接著，加入增黏劑（Viscoster — 50K)，使溶 解成黏稠液。於其中緩緩地加入規定量之高吸水性樹脂粉 末，於攪拌下恢復成室溫，調製使高吸水性樹脂粉末均勻 -34- 200808173 分散之油性凝膠狀體液漏出防止劑。 如此調製之體液漏出防止劑之吸水速度係與上述試驗 例1同樣地試驗。試驗結果係合倂如表4所示。 〔表4〕 試驗試樣No· (質量％) 實施例Να 18 19 20 21 22 處 方 Sunfme DM-200*1 67.8 57.8 64.5 54.5 58.6 PEG-200*2 10.0 10.0 15.0 高吸水性樹脂粉末*3 25.0 25.0 25.0 25.0 25.0 熱可塑性非離子型吸水性樹脂^ 7.0 7.0 丙烯酸聚合物之羧乙烯基聚合 物*5 0.4 親油性膨潤石*6 10.0 10.0 Viscoster 50K*7 0.2 0.2 0.5 0.5 2.0 結 果 形成至凝膠狀之時間（秒） <3次之平均値> 62 88 100 132 86 備 考 ” Sunfme DM-200 :三洋化成工業(股)製之聚環氧乙烷二甲基醚 ” PEG-200 :平均分子量約爲200之聚乙二醇 ^高吸水性樹脂粉末：住友精化(股)製，商品名「Aquakeep」 M熱可塑性非離子型吸水性樹脂：住友精化(股)製，商品名「Aquacok」 %丙烯酸聚合物之羧乙烯基聚合物：和光純藥工業(S受)製，商品名 「Hibiswako」 %親油性膨潤石：Coop Chemical (股)製，商品名^Rusentite」 Viscoster 5〇K :三井化學Polyurethane(股)製增黏劑(聚胺基甲酸乙酯樹脂） 試驗例2 (試驗原料之發熱度測定試驗） 試驗方法： 秤量l〇g之表5所示之各原料，放入於30ml之燒杯 ，接著，以下述條件測定注入8g之離子交換水時之混合 -35- 200808173 液之發熱溫度。 測定器：安立計器（股）製DATA COLLECTOR之液 體用溫度感應器。 測定時之室溫：22.3它。 試驗結果係合倂如表5所示。 〔表5〕 原料名 試驗次數 初期原料溫度 (°C ) 剛混合後之液溫 (°C ) 90秒後之液溫 .^_(〇C ) PEG200 第1次 23.9 35.0 —__x w /_ 31 7 第2次 25.1 37.8 ^ 1 無水甘油 第1次 24.9 28.0 —_________^ J > 1 —^^6 8 第2次 25.2 28.5 乙二醇 第1次 24.7 27.9 第2次 24.7 28.9 乙醇 第1次 24.2 28.0 2fi ^ 第2次 24.5 28.2 If. ^ 備考 PEG200 :平均分子量爲200之聚乙二醇 如上述表5所示，液狀P EG2 00時，與水混合時立即 發熱，迅速地可溶於水，並且可維持該溫度程度某些g g 之時間。相對於此，醇系溶劑之無水甘油、乙二醇、z _ 時，與水混合後僅些微發熱，該溫度程度相當低，1 i φ 不能維持該溫度程度。由此可知，液狀PEG200係適合於 提高高吸水性樹脂之吸液速度。 產業上利用性 本發明之體液漏出防止劑係藉由以注入器具注人胃體 -36 - ^ 200808173 之口、鼻、耳、肛門、女性陰道等之體腔，因爲於體腔內 與體液接觸時，迅速地吸收體液，膨潤而凝固，所以可有 效地使用於用以防止體液漏出之處理。 【圖式簡單說明】 〔圖1〕表示傳統的遺體處理裝置之使用狀態之槪略 斷面圖。 φ 〔圖2〕表示適合注入本發明之體液漏出防止劑之遺 體處理裝置之一種實施形態，（A)爲正面圖，（B)係左 側面圖，（C )右側面圖。 〔圖3〕沿著圖2所示之遺體處理裝置之中心軸線之 縱斷面圖。 〔圖4〕沿著圖2所示之遺體處理裝置之中心軸線之 橫斷面圖。. 〔圖5〕表示適合注入本發明之體液漏出防止劑之遺 ® 體處理裝置之插入管之縱斷面圖。 〔圖6〕表示適合注入本發明之體液漏出防止劑之遺 . 體處理裝置之其他實施形態，（A)爲正面圖，（B )係左 側面圖，（C )右側面圖。 〔圖7〕沿著圖6所示之遺體處理裝置之中心軸線之 縱斷面圖。 〔圖8〕沿著圖6所示之遺體處理裝置之中心軸線之 橫斷面圖。 -37- 200808173 【主要元件符號說明】 l，10，10a :注入器 20,20a :筒狀主體 21，21a :圓筒狀材料 22,22a :吐出口部份（吐出筒部份） 23 :停止部份 24 :突出條狀部份 φ 25,25a :覆蓋零件 26 :倒鈎部份 27,44 :制止部份 28 :舌片 29,29a ··保護蓋 3 0 :活塞 31活塞桿 32 :圓形凸緣部份 • 33 :凸緣部份 34 :橡膠墊 _ 3 5 :圓板狀部份 40 :插入管 42 :開孔部份 43 :連接部份 X :體液漏出防止劑 Y :纖維狀充塡材料 A :鼻孔 -38- 200808173-29- 200808173 [Table 1] Test sample No·mm%) Example No. Comparative Example 1 1 2 3 4 5 Prescription Sunfine DM-200*1 70 60 60 69 59 Ethylene Glycol • - 79.4 Carboxyvinyl Polymerization巧巧• 一雠0.2 Triethanolamine• • • A 0.4 PEG-200*3 • 10 • SANNONIC SS-120*4 10 10 Super Absorbent Resin Powder*5 25 25 25 25 25 20 Thermoplastic Nonionic Water Absorbent Resin *6 5 5 5 5 5 - Ethylcellulose 〃 (about 49% ethoxy) - - - 1 1 - (2) Day 1 100 100 100 100 100 100 Time to gel formation (seconds) (3 times) Average 値) 65 58 97 74 118 510 Preparation n SimfineDM-200: Polyethylene oxide dimethyl ether 2 carboxyvinyl polymer manufactured by Sanyo Chemical Industries Co., Ltd.: trade name "Hibiswako" and Kokon Pure Chemical Industries Co., Ltd. *3 PEG-2〇0: polyethylene glycol with an average molecular weight of about 2 M M SANNONIC SS-120: Sanyo Chemical Industry Co., Ltd. nonionic surfactant, ^ Polyethylene oxide alkyl Ether-based water-absorbent resin powder: trade name "Aquakeep" Sumitomo Seiki Co., Ltd. "Thermoplastic non-ionic water-absorbent resin: commodity "Aquacok" Sumitomo Elite Co., Ltd. "Ethylcellulose (about 49% ethoxy) ··············································· In the case of the first to fifth embodiments of the present invention, the addition amount of the superabsorbent resin powder is increased, and the dispersion stability is excellent when placed in a long period of time. Further, in comparison with Comparative Example 1, 'the addition amount of the superabsorbent resin powder is slightly increased', the time for the entire ion-exchanged water to be formed into a gel form can be greatly shortened. -30 - 200808173 It is understood that the body fluid of the present invention The leakage preventing agent is rapidly solidified into a solid gel having no fluidity, and is most suitable as a body fluid leakage preventing agent for preventing leakage of body fluids. Further, the polyethylene oxide dimethyl ether (sunfineDM) used in the above embodiments. 200), because it is a non-viscous, lightly flowing liquid, and is easily mixed with water, it is considered that the superabsorbent resin powder is easy to absorb water. However, when the injector is pressed in, the solvent comes out first. It is difficult to inject, so in order to make the composition viscous, PEG (polyethylene glycol) 2,000, S ANN ON IC SS - 120 is added as in Examples 2 and 3, and B is added as in Examples 4 and 5. A tackifier such as a cellulose is preferred. SANNONIC SS - 120 (polyethylene oxide alkyl ether) is made by dissolving ethyl cellulose (about 49% ethoxy) to increase adhesion. When ethyl cellulose increases the degree of substitution of ethoxy groups, it becomes soluble in a nonpolar solvent and is insoluble in a polar solvent. Usually, ethoxy substituted 43~50% is dissolved in a non-polar solvent. As in the above-mentioned Example 4, when 1% of ethyl cellulose was added, the water absorption speed was fast and the stability was also good, and an ideal oily gel-like body fluid leakage preventing agent which was not separated even after standing for a long period of time was prepared. However, since the water absorption rate tends to be deteriorated when a large amount of ethyl cellulose is added, the amount of ethyl cellulose added is preferably 0.2 to 5%, and 0.5 to 1.5 as in the above examples. % is especially good. In addition, when a solution in which ethyl cellulose is added to SANNONIC SS -1 20 and is viscous is added, when a solvent having a polarity is added, it is difficult to form a gel due to separation, so that it is preferable to avoid adding a polar solvent in such a combination. . In addition, as in Example 5, in the solution in which the ethylcellulose was dissolved in SANNONIC SS-120 and the viscosity was increased, the water absorption rate was slightly slower when the nonionic interface was used. It slides well and is smoothly injected and filled in the body cavity. (Examples 6 to 10) An oily gel-like body fluid leakage preventing agent which uniformly disperses the superabsorbent resin powder is prepared in the manner shown in Table 2 and the mixing ratio. The water absorption speed of the body fluid leakage preventing agent thus prepared was tested in the same manner as in the above Test Example 1. The test results are shown in Table 2. [Table 2] Test sample No. (% by mass) _ Price · 6 7 8 9 10 Prescription Sunfme DM-200*1 69.8 68.8 67.8 57.8 58.8 PEG-200*2 Exposure • - 10 - SANNONIC SS-120*3垂 - 10 Super Absorbent Resin Powder*4 25 25 25 25 25 Thermoplastic Nonionic Water-Absorbent Resin*5 5 6 7 7 6 Viscoster 50K*7 0.2 0.2 0.2 0.2 0.2 H 100 100 100 100 100 Result Formed to Condensate Glue time (seconds) (average of 3 times 5642 56 65 86 118 Preparation n Sunfme DM-200 ··Sanyo Chemical Industry Co., Ltd. made of polyethylene oxide dimethyl ether*2 PEG-200: average Polyethylene glycol with a molecular weight of about 200*3 SANNONIC SS-120: Nonionic surfactant made by Sanyo Chemical Industry Co., Ltd., Polyethylene oxide alkyl ether% superabsorbent resin powder: trade name "Aquakeep" Sumitomo Seiki Co., Ltd.*5 Thermoplastic non-ionic water-absorbent resin: trade name "Aquacok" Sumitomo Seika Co., Ltd. *6 ethyl cellulose (about 49% ethoxy) ··光纯药Industrial (stock) reagent *7 Viscoster 50K: Mitsui Chemicals Polyurethane (strand) tackifier (polyurethane resin) -32· 200808173 in Example 6 ~10" viscoster added as a tackifier - 50K (powder) is dissolved in an ether solvent (sunfineDM - 200) to make it a viscous liquid. In addition, Vis coster - 5 0K (powder) is also easily soluble in water. It is a viscous liquid. Therefore, Viscoster — 50K (powder) is the most excellent raw material for the tackifier of an ether solvent. However, when a large amount of oily gel is added, there is a tendency to become agglomerated because The injection into the injector becomes difficult, so as in the case of the above embodiment, the amount of Viscoster - 50K (powder) is preferably from 〇1 to 6%, preferably from 0. 1 to 2%. When the addition amount of the thermoplastic nonionic water-absorbent resin is increased as in Examples 8 and 9, the viscosity of the oily gel is improved, and the filling property of the injector is also improved. However, a large amount of thermoplasticity is added. In the case of the ionic water-absorbent resin, although the viscosity of the oily gel is increased, the water absorption speed tends to be slightly gradually deteriorated, so it is not preferable to add a large amount. Further, as in Example 9, a small amount of PEG is added. 2 0 0 Oil-based gel-like material becomes soft, charging Chen became smoothly. However, since it becomes a viscous liquid, the water absorption speed tends to be inferior, and it is not preferable to add a large amount. Similarly, as in Example 1, when a nonionic surfactant (SANNONIC SS-120) was added, since the water absorption speed tends to be deteriorated, it is not preferable to add a large amount. [Example 1] 1 to 1 7 An oily gel-like body fluid leakage preventing agent which uniformly disperses the superabsorbent resin powder is prepared in the manner shown in Table 3 and the mixing ratio. The obtained oily gel-like body fluid leakage preventing agent has an excellent water absorption speed. -33- 200808173 [Table 3] Test sample No. Example No. (% by mass) 11 12 13 14 15 16 17 Sunfine DM-200*1 68 67 67 - • - IONET DL-200*2 - • • 68 68 - IONET DO-400*3 • 雠• 68 68 Super absorbent resin powder M 25 25 25 25 25 25 25 Square thermoplastic nonionic absorbent resin % 6 6 6 • • Polyethylene oxide % 1 - one • one - polyvinyl methyl ether 2 sun 7 丨 7 • ethyl cellulose 7 (about 49% ethoxy) - - 2 - 7 - 7 Synthetic - 100 100 100 100 100 100 100 ” SimfmeDM-200: Sanyo Chemical Industry Co., Ltd. Polyethylene oxide dimethyl ether 40NETDL-200: Polyethylene oxide fatty acid diester made by Sanyo Chemical Industry Co., Ltd. (alias polyethylene glycol dilaurate) ) 3>3IONETDO-400: Polyethylene oxide fatty acid diester manufactured by Sanyo Chemical Industry Co., Ltd. (alias polyethylene glycol dioleate) M super absorbent resin powder: trade name "Aquakeep" Sumitomo Chemical (non-type) water-absorbent resin: trade name "Aquacok" Sumitomo Refinery (share)% Polyethylene oxide: trade name (PEO) Sumitomo Refinery Co., Ltd. "Ethylcellulose (about 49% ethoxy): Wako Pure Chemical Industries Co., Ltd. reagents Examples 18-22 placed in a quantitative ether solvent (sunfine DM-200) and PEG — 200 In a beaker, a certain amount of each of the dispersing agents shown in Table 4 below is added to the beaker, heated (dissolved at any temperature according to the dispersion stabilizer), and then added with a tackifier (Viscoster). — 50K), dissolved into a viscous liquid, in which a predetermined amount of superabsorbent resin powder is slowly added, and it is returned to room temperature under stirring to prepare a highly water-absorbent resin powder to be uniformly dispersed in an oil-based gel of -34-200808173. The water absorption rate of the body fluid leakage preventing agent prepared in this manner was tested in the same manner as in Test Example 1. The test results are shown in Table 4. [Table 4] Test sample No. (% by mass) EXAMPLES Να 18 19 20 21 22 Formulation Sunfme DM-200*1 67.8 57.8 64.5 54.5 58.6 PEG-200*2 10.0 10.0 15.0 Superabsorbent resin powder*3 25.0 25.0 25.0 25.0 25.0 Thermoplastic nonionic water-absorbent resin ^ 7.0 7.0 Acrylic Polymer Carboxyvinyl polymer *5 0.4 lipophilic bentonite *6 10.0 10.0 Viscoster 50K*7 0.2 0.2 0.5 0.5 2.0 Time to gel formation (seconds) <3 times average 値> 62 88 100 132 86 Remarks "Sunfme DM-200: Polyethylene oxide dimethyl ether made by Sanyo Chemical Industry Co., Ltd." PEG-200: Polyethylene glycol with an average molecular weight of about 200^Superabsorbent resin powder: Sumitomo Chemical system, trade name "Aquakeep" M thermoplastic non-ionic water-absorbent resin: Sumitomo Elite Co., Ltd. under the trade name "Aquacok"% Acrylic polymer carboxyvinyl polymer: Wako Pure Chemical Industries ( S-based system, trade name "Hibiswako" % lipophilic bentonite: Coop Chemical (stock), trade name ^Rusentite" Viscoster 5〇K: Mitsui Chemicals Polyurethane (strand) tackifier (polyurethane) (Resin) Test Example 2 (Test for the degree of heat generation of the test material) Test method: Each of the raw materials shown in Table 5 of the weight of l〇g was placed in a beaker of 30 ml, and then, when 8 g of ion-exchanged water was injected, the following conditions were measured. Mixing -35- 200808173 Liquid heating temperatureMeasuring device: Liquid temperature sensor for liquid body of DATA COLLECTOR made by Anlimeter. Room temperature at the time of measurement: 22.3 it. The test results are shown in Table 5. [Table 5] Raw material name test number Initial material temperature (°C) Liquid temperature immediately after mixing (°C) Liquid temperature after 90 seconds. ^_(〇C) PEG200 1st 23.9 35.0 —__x w /_ 31 7 2nd 25.1 37.8 ^ 1 Anhydrous glycerin 1st 24.9 28.0 —_________^ J > 1 —^^6 8 2nd 25.2 28.5 Ethylene glycol 1st 24.7 27.9 2nd 24.7 28.9 Ethanol 1st 24.2 28.0 2fi ^ 2nd 24.5 28.2 If. ^ Preparation PEG200: Polyethylene glycol with an average molecular weight of 200 is shown in Table 5 above. When liquid P EG2 00, it immediately heats up when mixed with water, and is rapidly soluble in water. And can maintain this temperature level for some gg time. On the other hand, in the case of anhydrous glycerin, ethylene glycol, and z _ of an alcohol solvent, it is only slightly heated when mixed with water, and the temperature is relatively low, and 1 i φ cannot maintain the temperature. From this, it is understood that the liquid PEG 200 is suitable for increasing the liquid absorption speed of the super absorbent resin. INDUSTRIAL APPLICABILITY The body fluid leakage preventing agent of the present invention is obtained by injecting a body cavity of a stomach, a nose, an ear, an anus, a female vagina, etc., by an injecting device, because when it is in contact with body fluid in a body cavity, It quickly absorbs body fluids, swells and solidifies, so it can be effectively used to prevent body fluids from leaking out. BRIEF DESCRIPTION OF THE DRAWINGS [Fig. 1] is a schematic cross-sectional view showing a state of use of a conventional body treatment device. φ [Fig. 2] shows an embodiment of a body treatment apparatus suitable for injecting the body fluid leakage preventing agent of the present invention, wherein (A) is a front view, (B) is a left side view, and (C) is a right side view. Fig. 3 is a longitudinal sectional view along the central axis of the body treatment device shown in Fig. 2. Fig. 4 is a cross-sectional view along the center axis of the body treatment device shown in Fig. 2. Fig. 5 is a longitudinal sectional view showing an insertion tube of a body treatment device suitable for injecting the body fluid leakage preventing agent of the present invention. [Fig. 6] shows a body fluid leakage preventing agent which is suitable for injection into the present invention. (A) is a front view, (B) is a left side view, and (C) is a right side view of another embodiment of the body treatment device. Fig. 7 is a longitudinal sectional view taken along the central axis of the body treatment device shown in Fig. 6. Fig. 8 is a cross-sectional view along the central axis of the body treatment device shown in Fig. 6. -37- 200808173 [Explanation of main component symbols] l,10,10a: injector 20, 20a: cylindrical body 21, 21a: cylindrical material 22, 22a: discharge port portion (spit portion) 23: stop Part 24: protruding strip portion φ 25, 25a: cover part 26: barb portion 27, 44: stop portion 28: tongue 29, 29a · protective cover 3 0: piston 31 piston rod 32: round Flange part • 33 : Flange part 34 : Rubber pad _ 3 5 : Disc-shaped part 40 : Insertion tube 42 : Opening part 43 : Connection part X : Body fluid leakage prevention agent Y : Fibrous Filling material A: Nostril -38- 200808173

B :咽喉部位 C :舌 D :氣管 E :食道 -39-B: Throat site C: Tongue D: Trachea E: Esophagus -39-

Claims (1)

200808173 十、申請專利範圍 1 · 一種遺體的體液漏出防止劑，其特徵爲，於含有 至少1種選自親水性的醚及酯所成群之溶劑（A )、及至 少1種選自聚環氧化物系之熱可塑性非離子型吸水性樹脂 " 、丙烯酸聚合物之羧乙烯基聚合物、丙烯酸聚合物之羧乙 ' 烯基聚合物/鹼中和劑、親油性蒙脫石、合成鋰蒙脫石、 天然鋰蒙脫石、及膨潤土所成群之分散安定劑（B )及/或 Φ 增黏劑（C )之黏稠液基劑中，分散高吸水性樹脂粉末（D )° 2 ·如申請專利範圍第1項之體液漏出防止劑，其中 該溶劑（A )係至少1種選自聚環氧乙烷二甲基醚及聚環 氧乙烷脂肪酸二酯所成群。 3 ·如申請專利範圍第1項或第2項之體液漏出防止 劑，其中該分散安定劑（B )係聚環氧化物系之熱可塑性 非離子型吸水性樹脂。 • 4.如申請專利範圍第1項至第3項中任一項之體液 漏出防止劑，其中該增黏劑（C )係至少1種選自聚胺基 _ 甲酸乙酯樹脂、聚乙烯醚、乙基纖維素及聚環氧乙烷所成 群。 5 ·如申請專利範圍第1項至第4項中任一項之體液 漏出防止劑，其中更含有至少1種選自與水混合時發熱之 液狀非離子性界面活性劑（Ε )及可溶於水之醇系有機溶 劑（F )所成群。 -40-200808173 X. Patent Application No. 1 A body fluid leakage preventing agent for a body characterized by containing at least one solvent (A) selected from the group consisting of hydrophilic ethers and esters, and at least one selected from the group consisting of poly rings Oxide-based thermoplastic nonionic water-absorbent resin", carboxyvinyl polymer of acrylic polymer, carboxy-ethylene polymer/alkali neutralizer of acrylic polymer, lipophilic montmorillonite, synthetic lithium Dispersing superabsorbent resin powder (D) ° 2 in a viscous liquid base of smectite, natural hectorite, and bentonite dispersed stabilizer (B) and/or Φ tackifier (C) The body fluid leakage preventing agent according to the first aspect of the invention, wherein the solvent (A) is at least one selected from the group consisting of polyethylene oxide dimethyl ether and polyethylene oxide fatty acid diester. 3. The body fluid leakage preventing agent according to the first or second aspect of the patent application, wherein the dispersion stabilizer (B) is a polyepoxide-based thermoplastic nonionic water-absorbent resin. 4. The body fluid leakage preventing agent according to any one of claims 1 to 3, wherein the tackifier (C) is at least one selected from the group consisting of polyamine-ethyl urethane resin and polyvinyl ether. Ethyl cellulose and polyethylene oxide are grouped together. 5. The body fluid leakage preventing agent according to any one of claims 1 to 4, which further comprises at least one liquid nonionic surfactant (Ε) selected from the group consisting of heat generated when mixed with water A group of alcohol-soluble organic solvents (F) dissolved in water. -40-
TW096123798A 2006-06-30 2007-06-29 Agent for prevention of leakage of body fluid from dead body TW200808173A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006182003A JP4081498B2 (en) 2006-06-30 2006-06-30 Body fluid leakage prevention agent

Publications (1)

Publication Number Publication Date
TW200808173A true TW200808173A (en) 2008-02-16

Family

ID=38845585

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096123798A TW200808173A (en) 2006-06-30 2007-06-29 Agent for prevention of leakage of body fluid from dead body

Country Status (3)

Country Link
JP (1) JP4081498B2 (en)
TW (1) TW200808173A (en)
WO (1) WO2008001820A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009179581A (en) * 2008-01-30 2009-08-13 Model Create:Kk Agent for preventing body fluid leakage for corpse and apparatus for preventing and treating body fluid leakage
JP5226615B2 (en) * 2009-06-23 2013-07-03 株式会社 モデルクリエイト Body fluid leakage prevention agent and body fluid leakage prevention method using the same
JP5226616B2 (en) * 2009-06-23 2013-07-03 株式会社 モデルクリエイト Body treatment device
KR101073668B1 (en) * 2009-08-13 2011-10-14 남승현 Composition for treating dead body
JP5926965B2 (en) * 2011-04-08 2016-05-25 住友精化株式会社 Body fluid leakage prevention agent
KR101384762B1 (en) * 2012-08-08 2014-04-14 남승현 Filter manufacturing method for preventing leakage of fluid from the body and a preparation method for preventing leakage of fluid from the body produced by the filter
WO2019039426A1 (en) * 2017-08-21 2019-02-28 住友精化株式会社 Water absorbent resin dispersion liquid, water absorbent resin coating film and method for producing same
JP2020193163A (en) * 2019-05-27 2020-12-03 株式会社ヒュー・メックス Dead body fluid leakage-prevention method
JP7008105B2 (en) * 2019-08-23 2022-02-10 梨沙 西原 How to seal the damaged or holed part of the body

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07265367A (en) * 1994-03-28 1995-10-17 Fujishiyoku Kagaku Kk Agent and method for sealing humor of corpse
JP2007099669A (en) * 2005-10-04 2007-04-19 Nishihara Risa Material for preventing leakage of body fluid from dead body

Also Published As

Publication number Publication date
WO2008001820A1 (en) 2008-01-03
JP4081498B2 (en) 2008-04-23
JP2008007485A (en) 2008-01-17

Similar Documents

Publication Publication Date Title
TW200808173A (en) Agent for prevention of leakage of body fluid from dead body
JP4029106B2 (en) Body fluid leakage preventing agent for corpse and body treatment apparatus using the same
JP2009179581A (en) Agent for preventing body fluid leakage for corpse and apparatus for preventing and treating body fluid leakage
AU2018225486A1 (en) Radiation activated gels that release fluids and assemblies containing the same
JP3586207B2 (en) Jelly-like body fluid leakage prevention material and body fluid leakage prevention method using the same
JP2007254350A (en) Apparatus for treating corpse
WO2021092271A1 (en) Hydrophilic medical products and hydration mediums for hydrating the same
JP2007099669A (en) Material for preventing leakage of body fluid from dead body
JPWO2004093540A1 (en) Body fluid leakage prevention device
JP5119408B2 (en) Insertion tube for injection of body fluid leakage preventive agent for corpse and corpse treatment apparatus using the same
JP5149504B2 (en) Body treatment device
JP4927416B2 (en) Body throat sealing device
US11083822B2 (en) Combination cellulose material and method of making same
CN115413997A (en) Viscoelastic composition and method for securing visual field of endoscope
US20220305233A1 (en) Reusable hydrophilic urinary catheter assembly
AU2015351167A1 (en) Teat pack material for milk-producing livestock, kit for forming teat pack for milk-producing livestock, and method for preventing mastitis in milk-producing livestock
JP4822873B2 (en) Body fluid leakage prevention device for corpses
WO2012137510A1 (en) Fluid leakage inhibitor
TW200913976A (en) Material for preventing leakage of body fluids from corpse and corpse treating device using the same
JP7444448B2 (en) Body fluid leak prevention agent
JP5486035B2 (en) Insertion tube for injection of body fluid leakage preventive agent for corpse and corpse treatment apparatus using the same
JP2008255025A (en) Apparatus for treatment of dead body
JP2007182445A (en) Apparatus for preventing leakage of humor from dead body
JP2010530408A (en) Biocidal capsules, formulations containing them, and sanitary pads containing the formulations
JP5013837B2 (en) Body treatment device